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Abstract
Despite declines in mortality risks of myocardial infarction (MI) and stroke in the
US since the 1960‟s, the burdens of these conditions remain high. These conditions
require emergency and specialized care and therefore quick transportation of patients to
appropriate hospitals is critical. Geographic disparities in MI and stroke burdens have
been consistently reported in the US with the south-east having the highest risks. Most
studies of geographic disparities have been performed at county or higher geographic
units. Therefore, spatial patterns at neighborhood levels are unclear. Moreover, it‟s
important to investigate disparities at neighborhood levels to better understand
neighborhood health needs. Therefore, the goal of this study was to investigate
neighborhood disparities associated with MI and stroke in Middle Tennessee. Specific
objectives were to investigate: (a) geographic disparities in timely access to emergency
care; and (b) geographic disparities in MI and stroke mortality risks.
Street network, hospital, population, and mortality data (1999-2007) were
obtained from Streetmap USA, the Joint Commission on Accreditation of Health
Organizations, US Census Bureau, and the Tennessee Department of Health,
respectively. Network analysis was used to investigate and identify neighborhoods
lacking timely access to emergency MI and stroke care. Moran‟s I and Kulldorff‟s spatial
scan statistic were used to investigate geographic hot-spots of MI and stroke mortality
risks at both the county and neighborhood levels. Poisson and negative binomial
models were used to investigate predictors of identified geographic patterns.
A temporal increase in the percentage of the population with timely geographic
access to stroke and cardiac centers was observed. In 2010, about 5% of the
iv

population, located mainly in rural neighborhoods, lacked timely access to a stroke
center. Significant (p<0.05) hot-spots of MI and stroke mortality risks were identified at
both neighborhood and county levels. However, clusters identified at the neighborhood
level were more refined. Neighborhoods with higher proportions of older populations
and those with lower education had significantly (p<0.05) higher mortality risks.
These findings are vital for guiding health planning, resource allocation and
service provision in an effort to provide needs-based services to the population. This is
important in reducing/eliminating neighborhood disparities and improving population
health.
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CHAPTER 1

1.0 Introduction

Myocardial Infarction (MI), also known as heart attack, occurs as a result of
blockage of blood flow to the heart muscle resulting mainly from formation of a blood
clot in the coronary artery. Stroke is an acute neurological injury which results from
interrupted blood supply to part of the brain. Globally, an estimated 17 million people die
annually of Cardiovascular diseases (CVD), particularly MI and stroke [1]. Myocardial
infarction, accounts for about 7.2 million deaths globally each year [2] . About 16 million
new incidences of stroke occur annually in the world, resulting in a total of 5.7 million
deaths [3].

Although the mortality risks from coronary heart disease (CHD) and stroke have
declined steadily in the US since the 1960‟s, heart disease and stroke remain the first
and third leading causes of death in the US [4]. Stroke is also the leading cause of adult
disability in the US [5]. An estimated 700,000 individuals suffer a stroke each year in the
United States. Out of these, about 167,000 die [3] and about 15-30% of the survivors
are severely disabled [5]. In Tennessee, heart attack accounts for over one-third of all
diseases of the heart deaths and results in an average of 5,500 deaths per year [6].
Stroke is also the leading cause of adult disability and third leading cause of death in
Tennessee [6]. Additionally, about 20,000 hospitalizations for stroke were recorded
each year between 1997 and 2004 in Tennessee [6].
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Both MI and stroke are serious conditions that require emergency medical care
to reduce chances of complications or death. Percutaneous coronary intervention (PCI),
which involves cardiac catheterization, is the recommended treatment for MI. Since
timely access to this treatment is critical for good health outcomes [7, 8], quick access
to cardiac centers plays an important role in determining patient survival. For acute
ischemic stroke, the recommended treatment (administration of thrombolytics) has to be
done within 3 hours of symptom onset [9] for better outcomes. There is evidence that
half of stroke deaths occur before the patients reach the hospital [10]. Therefore, early
transport of patients to appropriate hospitals and early treatment of these patients may
prevent or reduce the number of complications, disabilities or deaths [11].

Several factors such as reduction in major population risk factors and improved
medical care have been attributed to the decline in the MI and stroke mortality risks [1215] over the past decades [16-19]. Despite the declines in MI and stroke mortality risks,
a disproportionate burden of these conditions is reported to be shouldered by some
segments of the population [20]. Significant variability of MI and stroke mortality risks
have been observed across geographic regions, races, genders, age groups, and
socioeconomic status [14]. The Southeastern United States, also known as the “stroke
belt” has about 20% greater average mortality risk than the other regions of the United
States [21]. Investigation and identification of these disparities in health outcomes at the
local level and identifying determinants for the identified disparities is critical in informing
local health planning and policy decisions. Additionally, identification of disparities in
geographic access to emergency cardiac and stroke care is a critical step towards
2

reduction and elimination of these disparities, and improving population health. Many
past studies assessing geographic access to health services have used straight
line/Euclidean distance. However, these methods have inherent limitations as they
assume straight line driving and do not adjust for travel impedances. In this study,
network analysis was used to estimate travel time. This is better because it accounts for
travel impedances such as speed limits and therefore provides a more realistic and
accurate measure of geographic accessibility than use of Euclidean distance measures
[22].

The objectives of this study were to investigate: (i) spatial and temporal changes
in disparities of timely access to emergency heart attack and stroke care in Middle
Tennessee (ii) neighborhood geographic disparities and temporal trends in heart attack
and stroke mortality risks in Middle Tennessee and identify determinants/predictors of
observed disparities. Identification of disproportionately affected neighborhoods will help
health planners better target resources and can aid the development of programs better
tailored to specific community needs. This is important in addressing one of the
overarching goals of the Healthy People 2020 of reducing disparities and improving
health of the entire population [23].

This thesis is divided into four chapters. Chapter one includes the introduction of
the study as well as literature review. In chapter two, I present results of a study in
which network analysis was used to address the first objective of the study and in
chapter three, results of a study addressing the second objective are presented.

3

Chapter four provides a general summary of the thesis, recommendations and
concluding remarks.
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1.1 Literature Review
1.1.1 Pathophysiology
Myocardial infarction (MI) occurs when a coronary artery supplying the heart
becomes occluded. The occlusion impedes the flow of oxygen rich blood to the heart
muscle thus causing muscle death. The prognosis of patients after an acute MI is
mainly determined by the size of the infarct, which is dependent on the area at risk
(determined by localization of coronary occlusion), the duration and severity of
ischaemia, as well as the mode of reperfusion [24]. Prompt reperfusion restores blood
flow and limits the extent of damage.
Stroke is brain injury caused by interruption of blood supply to the brain, usually
as a result of bursting, narrowing or blockage of a blood vessel. Stroke is characterized
by rapid onset of neurological symptoms that last at least 24 hours. Blockage of blood
supply deprives the brain of necessary oxygen and nutrients resulting in damage to the
brain tissue. The impact of stroke is dependent on the part of the brain that is damaged,
how quickly blood flow is restored, and how quickly other areas of the brain can
compensate for the injury [25]. There are two main types of stroke: hemorrhagic and
ischemic. Ischemic stroke, which is the main focus of this study, accounts for 87% of the
780,000 stroke cases that occur annually in the United States [26].
1.1.2 Etiology
A large number of cases of MI occur as a result of coronary artery disease (CAD)
[27]. Coronary artery disease results from progressive buildup of fatty deposits, called
plaque, on the inner walls of the coronary arteries. This condition is called
5

atherosclerosis and involves the walls of the arteries thickening and accumulating
plaque that result in narrowing or blockage of one or more of the arteries supplying a
section of the heart muscle. In some cases, rupture of destabilized atherosclerotic
plaques inside the arterial wall may trigger the formation of a thrombus which can
occlude the artery thus causing cardiac ischemia [28, 29]. Occlusion of the coronary
artery impedes blood flow thus causing a heart attack. A heart attack can also occur
due to microvascular disease, a condition in which the blood vessels of the heart are
very small or microscopic. This condition is believed to be more common in women than
in men [27]. A less common cause of MI is severe spasm (tightening) of a coronary
artery that cuts off blood flow through the artery. Spasms can also occur in nonatherosclerotic coronary arteries. The causes of coronary artery spasm are not clear,
however, they are usually associated with taking certain drugs (such as cocaine),
emotional stress or pain, exposure to extreme cold and cigarette smoking.

Ischemic stroke results from occlusion of an artery in the cerebral circulation. The
blockages stem from three conditions: (i) formation of a clot within a blood vessel of the
brain or neck, called thrombosis; (ii) movement of a clot from another part of the body
such as the heart to the neck or brain, called embolism; (iii) severe narrowing of an
artery in or leading to the brain, called stenosis. Hemorrhagic stroke occurs when there
is bleeding within the brain (intracerebral hemorrhage) or bleeding between the inner
(pia mater) and outer (arachnoid mater) layers of the tissue (meninges) covering the
brain (subarachnoid hemorrhage). Intracerebral hemorrhage usually results from
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chronic high blood pressure whereas the most common cause of subarachnoid
hemorrhage is rupture of an aneurysm in an artery.

1.1.3 Clinical Presentation
Chest pain or discomfort is the most common symptom of MI [27] . There is
discomfort, in the center of the chest, that lasts for more than a few minutes, subsides,
and reoccurs. This discomfort may be mild or severe and is characterized by
uncomfortable pressure, squeezing, or pain. Heart attack pain sometimes manifests as
indigestion or heartburn. Other common signs and symptoms of MI include: upper body
discomfort in one or both arms, the back, neck, jaw, or stomach; shortness of breath;
nausea, vomiting, lightheadedness or fainting and breaking out in a cold sweat. In
women, MI symptoms may be different from the typical symptoms. For instance, some
women may experience symptoms such as, shortness of breath, indigestion, or fatigue
[25]. This makes diagnosis more complex.

The five main categories of stroke symptoms defined by the American Stroke
Association (ASA) are: (i) sudden numbness or weakness of the face, arm or leg,
especially on one side of the body; (ii) sudden confusion, trouble speaking or
understanding; (iii) sudden trouble seeing in one or both eyes; (iv) sudden trouble
walking, dizziness, loss of balance or coordination; and (v) sudden severe headache
with no known cause [30]. Other signs that may occur include double vision,
drowsiness, and nausea or vomiting. In a multicenter study carried out in Japan, it was
found that motor weakness accounted for 70% of all symptoms occurring at the onset of
ischemic stroke, speech disturbance (46%), and gait disturbances (37%) [31].
7

1.1.4 Diagnosis
1.1.4.1 Myocardial Infarction

Patient symptoms, personal and family medical history and results of diagnostic
tests form the basis for MI diagnosis. The World Health Organization (WHO) criteria for
the diagnosis of MI require that at least two of the following three factors be present: a
history of ischemic type chest discomfort, evolutionary changes on serially obtained
Electrocardiogram (ECG) tracings, and a rise and fall in serum cardiac markers [32].
The ECG is a test that detects and records the electrical activity of the heart. Injured
muscle does not conduct electrical impulses normally, therefore, certain changes in the
appearance of the electrical waves on an ECG are strong evidence of a heart attack.
Electrocardiography is the most commonly used laboratory procedure for the diagnosis
of heart disease [33] and is readily available, non-invasive, and inexpensive. The ECG
not only indicates the presence of acute MI, but can also be used for estimation of the
size and location of the affected area [34].

Appropriate and accurate interpretation of the ECG recording requires knowledge
about its sensitivity and specificity. However, when considering the sensitivity and
specificity of the ECG, it is important to recognize that the ECG is composed of a
number of waveforms, each with its own sensitivity and specificity, and each influenced
differently by a variety of pathologic and pathophysiologic factors [33]. Nevertheless, a
study in Scotland reported a 68% sensitivity, 100% specificity and 85% predictive
accuracy of ECGs in diagnosing MI [35].
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Blood tests such as troponin, creatine kinase (CK) and serum myoglobin tests
measure the amount of proteins in the bloodstream released as a result of damaged
cardiac muscle cells. Elevated blood levels of these proteins especially, Creatine
kinase-myocardial band (CK-MB) isoenzyme, are strong evidence of MI [27, 36].
Recently, troponin I enzyme determinations have become critical in early evaluation of a
suspected MI because they rise earlier than the CK-MB isoenzyme and levels may stay
elevated for several days. Creatine kinase levels usually rise about 6 hours after an
infarction and may return to normal within 48 hours [36]. In a study that compared the
diagnostic accuracy of these markers, CK-MB subforms (isoforms) (for example, CKMB2 and CK-MB1) were most sensitive (91%) and specific (89%) within 6 hours of
onset, followed by myoglobin with sensitivity of 78% and specificity of 89%. For late
diagnosis, total CK-MB activity (derived from subforms) was the most sensitive (96%)
and specific (98%) at 10 hours from onset, followed by troponin I that had a sensitivity of
96% and specificity of 93% at 18 hours, and troponin T with a sensitivity of 87% and
specificity of 93% at 10 hours [37]. However, based on the predictive values analysis,
Weissler argues that CK-MB subforms have no greater early rule-in power for MI than
troponins T and I, CK-MB activity and mass; and that CK-MB subforms have the highest
rule-out power only at the sixth hour after chest pain onset [38]. Recently, studies [3941] have shown that compared to other cardiac biomarkers such as CK-MB and
myogloblin, cardiac troponin demonstrates high sensitivity and specificity, with the ability
to detect even minor amounts of myocardial damage. Hence, there is evidence to
support the role of troponins both in the diagnosis of MI, as well as for post-infarction
risk assessment. It is important to note that the sensitivity and specificity of the troponin
9

I assay depends on the cut-off values. For instance, a study investigating the sensitivity
of troponin I, revealed that when a troponin I level greater than 0.6 ng/mL was used as a
positive value (cut-off value), the sensitivity was 94% and specificity was 81% using
either time zero or 6 hours. Similarly, when troponin I greater than 2.0 ng/mL was used
to define a positive test, the sensitivity was 85% and specificity was 91% [42].
Coronary Angiography, a special x-ray exam of the heart and blood vessels, is
done in MI patients to help identify blockages in the coronary arteries. A number of
sophisticated techniques such as coronary computed tomography, magnetic resonance
imaging (MRI) and positron emission tomography (PET) can be used to visualize and
identify stenosed or blocked coronary arteries thus help in diagnosis of MI. In a study
done in New York, coronary computed tomographic angiography was found to have a
sensitivity of 100% and a specificity of 73%, with a positive predictive value of 92%, and
a negative predictive value of 100% for diagnosing obstructive CAD [43]. Another study
carried out in Switzerland reported that the sensitivity and specificity for ischaemia
detection by cardiovascular MRI were 91% and 94%, respectively, and for detection of
coronary arteries with ≥50% diameter stenoses, the study found that the sensitivity and
specificity of MRI were 87% and 85%, respectively [44]. The average weighted
sensitivity of 90% and specificity of 89% was observed for detecting at least one
coronary artery with >50% stenosis when PET was used [45]. In the same study, a
positive predictive value of 94% and a negative predictive value of 73% was recorded
for PET with the overall diagnostic accuracy of 90%.
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1.1.4.2 Stroke
Like MI, patient symptoms, personal and family medical history and results of
diagnostic tests form the basis for stroke diagnosis. A complete physical and
neurological exam, a series of questions and tests to check brain, spinal cord, and
nerve function, are performed. The neurological exam checks a person‟s mental status,
coordination, ability to walk, and how well the muscles, sensory systems, and reflexes
work. In a community-based study of diagnostic accuracy, primary care physicians
practising in an emergency setting had a 92% sensitivity for diagnosis of stroke and
transient ischemic attack (TIA) based on physical and neurological examination of
patients [46].
A computed tomography (CT) scan of the brain is performed as part of the initial
evaluation of a patient with suspected stroke. A CT scan is a brain imaging test that
uses low-dose x-rays to show an image of the brain. This test has a low sensitivity to
early ischemic changes during acute cerebral ischemia and is usually of little value for
establishing the diagnosis of acute stroke. However, the main advantage of this imaging
modality is its widespread availability and high sensitivity for hemorrhagic stroke [47]. It
is able to eliminate the possibility of intracranial hemorrhage, subdural hematoma, or
mass lesion. A study reported a sensitivity of 12% and specificity of 100% of CT in
diagnosing acute ischemic stroke within 3 hours of symptom onset [48]. Multimodal
imaging techniques such as CT angiography and CT perfusion techniques may also
add diagnostic information regarding vascular occlusion but are not widely available on
a timely basis at many hospitals [49].

11

Magnetic resonance imaging is another technique that uses magnetic fields to
detect subtle changes in brain tissue and is used to show the location and extent of
brain damage. Magnetic resonance imaging based techniques have shown greatly
enhanced sensitivity in the early diagnosis of stroke as well as the identification of
intracerebral hemorrhage [50]. A study reported a sensitivity of 76% and a specificity of
96% of MRI in diagnosing acute stroke within 3 hours of symptom onset, whereas a
sensitivity of 91% and specificity of 98% was reported for the same diagnosis within 12
hours of symptom onset [48]. Additionally, diffusion-weighted imaging (DWI), another
MRI imaging technique, is able to demonstrate parenchymal changes early in the
presentation of stroke [47]. Magnetic resonance imaging produces sharper and more
detailed images than a CT scan so it's often used to diagnose stroke involving small
blood vessels [51]. However, as a practical issue, most hospitals do not have these
specialized MRI services available in the acute setting, and these diagnostic tools
require more advanced interpretations. Therefore, although multimodal imaging
techniques may provide valuable information, these diagnostic techniques may be
difficult to perform in a timely fashion [47, 49].
Techniques such as transcranial doppler, doppler ultrasound, carotid ultrasound
are used to assess blood flow through the vessels in the brain. These tests give
information about the condition of arteries. In carotid artery ultrasound scanning, highpitched sound waves are bounced off the blood vessels and tissues of the neck to
create an image of the arteries. Duplex scanning, which is a newer technique than
traditional carotid artery ultrasound and now used more often, is able to measure blood
flow at many points in the blood vessel at one time. The transcranial doppler is a non12

invasive tool for studying the basal cerebral arteries, and has been widely used for
evaluating ischemic stroke [52]. Carotid duplex sonography has also been widely used
as a tool to evaluate occlusive lesions in the extracranial brain arteries such as the
internal carotid artery and vertebral artery [53-55]. The accuracy, sensitivity, and
specificity of neurosonography in detection of occlusive vessels in ischemic stroke was
found to be 99.6%, 100% and 99.6%, respectively [56]. Additionally, neurosonographic
examination is noninvasive, convenient, relatively inexpensive and can be performed at
the bedside.
Cerebral angiography (digital subtraction angiography [DSA]) is the gold
standard for the detection of many types of cerebrovascular lesions and diseases [57].
Digital subtraction angiography is an invasive test which involves taking an x-ray of the
brain arteries after injection of a contrast dye in the vessels. This test gives a picture of
the blood flow through the vessels, thus allows identification of the size and location of
blockages. In this test, a catheter is inserted into an artery (often in the arm) and
threaded through other blood vessels to reach the carotid artery. A dye is then injected
through the tube and into the artery. The dye outlines the blood vessel and x-rays are
taken to evaluate the degree of narrowing and the condition of a plaque. For most types
of cerebrovascular disease, the resolution, sensitivity (95%), specificity (99%) and
accuracy (97%) of DSA equal or exceed that of the non-invasive techniques [58-60].
However, a risk of about 1% mortality and serious morbidity has been associated with
DSA procedures [61, 62].
Since approximately 20-40% of all ischemic stroke cases are caused by emboli,
usually arising from the heart [63], imaging procedures such as transthoracic and
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transesophageal echocardiography are intended to guide clinical decision making by
detecting the cardiac sources of cerebral ischemia or infarction. Both the sensitivity and
specificity of transesophageal echocardiography in detecting cardiac anomalies
implicated in stroke have been reported to be 99% [64].
1.1.5 Treatment
1.1.5.1 Myocardial Infarction
Limiting the size of the infarct is critical to improving immediate and long-term
outcomes and to reducing the incidence and prevalence of heart failure. The primary
therapy to limit infarct size in patients with an acute MI is reperfusion by
revascularization with a mechanical (percutaneous coronary intervention, also known
as, angioplasty) or pharmacological intervention (thrombolysis). Other treatments like
pain control, surgical procedures such as coronary artery bypass, and heart
transplantations may be performed. Angioplasty is the recommended treatment for MI
and is a less invasive procedure that can be used to open coronary arteries that are
blocked. During angioplasty, a catheter with a balloon on the end is threaded through a
blood vessel to the blocked coronary artery. Then, the balloon is inflated to push the
plaque against the wall of the artery thus widening the inside of the artery, restoring
blood flow. Sometimes, a small mesh tube called a stent may be inserted into the artery
to help keep it open. Insertion of a stent reduces the possibility of the artery narrowing
again in the same place (restenosis) but is not associated with significant reductions in
death or reinfarction rates [65, 66]. Restenosis occurs in about 40% of patients that
undergo angioplasty alone, and in 20% of those that undergo angioplasty with stenting
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[25]. Studies have shown that drug-eluting stents reduce the risk of restenosis
compared with bare metal stents, without having a significant impact on the risk of stent
thrombosis, recurrent myocardial infarction, and mortality [67-69]. Primary PCI
approaches a 90% success rate [70] and is effective in securing and maintaining
coronary artery patency and prevents some of the bleeding risks associated with
fibrinolysis. Several studies have shown the superiority of PCI procedures over
thrombolytics in the treatment of acute myocardial infarction [71-74]. There is evidence
of reduced mortality and recurrence rates in early catheterization patients as compared
to those given thrombolytic therapy. Additionally, lower mortality risks have been
observed in patients undergoing primary PCI in centers with a high volume of PCI
procedures [75, 76].
Pain control or analgesia is an important element in the management of MI
patients, not only for humane reasons but also because the pain is associated with
increased sympathetic activation, which causes vasoconstriction and increases the
workload of the heart [77]. Intravenous opioids such as morphine are the most common
analgesics used. Morphine lessens anxiety and restlessness and reduces sympathetic
activation, thus decreasing the workload and oxygen consumption of the heart [78].
Other drugs like nitrates decrease ischemic discomfort through coronary vasodilation
which enhances coronary blood flow and also decreases ventricular preload by
increasing venous capacitance. Additionally, supplementary oxygen is recommended
for most MI patients especially those with breathlessness (shortness of breath) and
hypoxia [78]. Thrombolytic therapy is also used and involves administration of
thrombolytic agents (clot busters) to dissolve clots in the arteries thus restoring blood
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flow to the heart tissue. The use of thrombolytics, such as tissue plasminogen activator
(tPA), has substantially reduced disability and death from heart attacks [25].
Coronary artery bypass graft (CABG) is a surgical procedure in which a new
route is created for blood to flow around or bypass a clogged artery. This is performed
to restore adequate blood supply to the heart. This procedure is done by removing a
part of a vein from the patient‟s leg or thigh, or an artery from the chest wall or arm, and
grafting this segment to a blocked coronary artery to form a detour around the blockage.
Although the indication of a CABG in the acute phase is limited to a few patients, it may
be indicated after failed PCI, coronary occlusion not amenable for PCI, presence of
refractory symptoms after PCI, cardiogenic shock, or mechanical complications such as
ventricular rupture, acute mitral regurgitation, or ventricular septal defect [79, 80].
Patients that have undergone CABG have been shown to have a long-term survival of
35 years [81, 82].
Cardiac transplantation is indicated for patients with irreversible heart injury from
CAD and multiple heart attacks that cannot be treated by any other means. According to
a survey conducted by the American Heart Association (AHA), the average survival
rates, one year after the transplant are 88% in males, and 86.2% in females. This
average has been found to steadily decline as the years progress and so the five year
survival rates are found to be 73.1% in males, 69.0% in females [21].
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1.1.5.2 Stroke
The treatment for stroke is dependent on the type of stroke (Ischemic or
hemorrhagic).
1.1.5.2.1 Ischemic Stroke

Before or on arrival at the hospital, ischemic stroke patients may be given
antiplatelet drugs (such as aspirin or clopidogrel) to prevent clotting. The primary
treatment for acute ischemic stroke is early administration of thrombolytic medication or
“clot-buster” called tissue plasminogen activator (tPA). Tissue plasminogen activator
dissolves the clot and restores blood flow to the brain. However, it presents some risk of
causing bleeding in the brain in some people. Due to this risk, it is recommended that
tPA be administered only by physicians trained in its use and in facilities with the
necessary resources to handle the bleeding complications [12]. In the National institute
of neurological disorders and stroke (NINDS) tPA stroke study, 50% of tPA treated
patients had excellent outcomes compared with 38% of controls at 3 months after
treatment [9]. However, the mortality risk at 3 months was not significantly different
between the two groups and a higher rate of symptomatic hemorrhage was observed in
the tPA group than the control group (6.4% versus 0.6%).

Patients who are beyond the 3-hour window restriction of intravenous tPA
treatment may benefit from mechanical thrombolysis. The

Concentric Retriever

(Concentric Medical, Mountain View, Calif) is the only device currently approved by the
U.S. Food and Drug Administration (FDA) for the endovascular treatment of stroke
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patients [83]. This device is used to mechanically remove occlusions from major
cerebral arteries. The device has been reportedly used in patients with occlusion
involving either the internal carotid artery, a segment of the middle cerebral artery, the
basilar, or vertebral arteries [84].

Intra-arterial thrombolysis (IAT) is a procedure in which recanalization is
achieved by direct infusion of a fibrinolytic agent (such as urokinase) into the clot
causing the arterial occlusion. This endovascular approach is restricted to the
recanalization of major cerebral arteries, most commonly the middle cerebral artery.
Lisboa and colleagues [85] reported more favorable outcomes (41.5% versus 23%) and
a lower mortality risk (27.2% versus 40%) in IAT treated patients than in the control
group. However, symptomatic intracerebral hemorrhage was more frequent in the IAT
group compared with the control group (9.5% versus 3%).

Carotid endarterectomy (CEA) is a common surgical procedure performed to
prevent or treat stroke in selected patients with high-grade atherosclerotic occlusive
disease of one or both carotid arteries [86]. Several controlled trials have provided
evidence that carotid endarterectomy is superior to medical therapy in reducing
subsequent stroke rates among subgroups of persons at risk [87-90]. For instance, high
beneficial effects of CEA were observed in patients with angiographically confirmed
high-grade carotid stenosis (70% to 99%) [87]. Although this procedure may reduce the
risk of ischemic stroke, it may also trigger a stroke or heart attack by releasing a blood
clot or fatty debris. This risk can be reduced by placing filters (distal protection devices)
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at strategic points in the blood stream to trap any material that may break free during
the procedure.

Angioplasty as done in the management of MI can also be done to widen the
inside of a plaque-coated artery that supplies blood to the brain. A balloon-tipped
catheter is maneuvered into the obstructed area of the artery, and the balloon is inflated
compressing the plaques against the artery walls. Sometimes a stent is inserted in the
artery to prevent recurrent narrowing. Although carotid angioplasty and stenting (CAS)
is a potential alternative treatment to CEA, some randomized trials and meta-analyses
have failed to demonstrate that CAS is as safe as CEA with regard to the risks of
periprocedural complications [91-95], and current guidelines recommend that CAS
should not be used in good surgical candidates [96-98]. Nonetheless, some clinical
trials have shown that beyond the perioperative period, the risk of ipsilateral stroke is
very low and comparable in CAS and CEA patients [99, 100], suggesting that CAS may
be an acceptable option in selected patients who have a low risk of periprocedural
complications [101]. Carotid angioplasty and stenting is said to be superior to CEA in
certain patient groups, such as those exposed to previous neck surgery or radiation
injury, and in patients at high risk of complications with surgical therapy [102]. In their
review of literature, Kachel et al reported an overall technical success rate of 96.2%,
with a 2.1% rate of morbidity, 6.3% rate of transient minor complications, and no deaths
for carotid angioplasty procedures [103].
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1.1.5.2.2 Hemorrhagic Stroke

Intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH) account
for about 10% and 3% of all stroke cases in the US, respectively [21]. Potential
treatments of hemorrhagic strokes include stopping or slowing the initial bleeding during
the first hour after onset; removing blood from the parenchyma or ventricles to eliminate
both mechanical and chemical factors that cause brain injury; management of
complications of blood in the brain, including increased intracranial pressure (ICP) and
decreased cerebral perfusion; and good general supportive management of patients
with severe brain injury [104]. Although there is no clear indication from the literature of
the optimal treatment for hemorrhagic stroke, surgical treatment is common [105, 106].
The rationale for surgery is evacuation of a hematoma so as to reduce the mass effect,
block the release of neuropathic products from the hematoma, and prevent prolonged
interaction between the hematoma and normal tissue, which can initiate pathologic
processes [107].

In practice, surgery is recommended as a lifesaving measure in

patients with large hematomas or in young patients with cortical hemorrhages and
secondary neurologic deterioration. Patients with great and prolonged neurologic
deficits are considered poor surgical candidates as they are believed to have little
chance for functional recovery. Patients with small hemorrhages or minimal neurologic
deficits are treated medically and deep hemorrhages are rarely evacuated [104]. Early
craniotomy has been recommended in patients with cerebellar hematomas because the
rate of neurologic deterioration after cerebellar hemorrhage is very high and
unpredictable [108]. Zuccarello et al reported a higher likelihood of a good outcome in
20

ICH patients who underwent surgical evacuation (56%) than in those who received
medical treatment alone (36%) [109]. However, the benefits of evacuation of basal
ganglionic, thalamic, and pontine hemorrhages through an open craniotomy have been
obscured by excessive neural damage incurred during the approach to the hematoma
and bleeding recurrence [108]. Additionally, a study reported a higher rate of death or
dependency at 6 months associated with this procedure [110].

1.1.6 Timeliness of Access to Myocardial Infarction and Stroke Care

Time is critical in diagnosis and management of MI and stroke. A quick diagnosis
enables administration of proper treatment for better outcomes. Therefore, quick
recognition of MI and stroke symptoms and timely transportation of the patients, by
either Emergency medical services (EMS) or other means, to the nearest cardiac and
stroke center is of paramount importance.

Successful use of catheterization, the recommended treatment for MI, depends
on the time to treatment. The current American and European guidelines suggest
cardiac catheterization be done within 90 minutes of first medical contact [7, 8]. In
situations when the time window for cardiac catheterization has been exceeded, it is
recommended that thrombolytic therapy be given in the treatment of MI if there are no
contraindications [7, 111]. However, for better outcomes, thrombolytic therapy must be
administered within 1 hour after the onset of MI symptoms [27]. Thrombolytic therapy
has been shown to greatly reduce risk of death in high risk patients presenting within 12
hours of MI symptom onset [112]. Furthermore, it is estimated that thrombolytic therapy
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prevents about 30 early deaths per 1,000 patients treated, with 20 deaths prevented per
1,000 patients treated between 7 and 12 hours after symptom onset [113].

For ischemic stroke, thrombolytic therapy, the main treatment must be
administered intravenously within 3 [13] or 4.5 hours [114] of the onset of stroke
symptoms. However, even within the 3-hour recommended treatment window, the odds
of improvement decrease as time from symptom onset to treatment increases [14].
Therefore, quick transportation of MI and stroke patients to the appropriate hospitals is
very critical in reducing mortality and improving the health outcomes. Moreover, due to
the risks involved in thrombolytic therapy, it is recommended that it is administered only
by physicians trained in its use and in hospitals with the necessary resources to handle
bleeding complications [115]. This implies that not all hospitals can provide appropriate
care for these patients. Thus, it‟s recommended that MI patients be treated in cardiac
centers and stroke patients in stroke centers.

1.1.7 Role of Emergency Medical Services in Myocardial Infarction and Stroke
Care

Successful MI and stroke care begins with recognizing these conditions as
medical emergencies. Therefore, EMS play a key role in the continuum of care for these
patients. Emergency medical services respond to, stabilize, and transport patients and
therefore play an important role in saving lives and ensuring timely transport of patients
in need of life saving cardiac procedures [116] and stroke care [117]. Emergency
medical services are the first medical contact for more than half of all patients who have
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a stroke [118], and EMS transport significantly shortens the arrival time of patients to
hospital [117] as well as reduces the time from symptom onset to CT evaluation [119121]. Studies have also shown that myocardial infarction patients who are transported
to the hospital by ambulance rather than by friends or relatives are more likely to
receive early reperfusion therapy since they tend to arrive at the hospital earlier [116,
122, 123].
Early identiﬁcation of MI and stroke symptoms by EMS personnel is a valuable
part of optimal care for MI and stroke patients. In order to optimize stroke identiﬁcation
in the ﬁeld, prehospital professionals are trained in appropriate use of prehospital stroke
screening tools, such as the Los Angeles prehospital stroke screen (LAPSS) or the
Cincinnati prehospital stroke scale (CPSS). Both of these stroke screening instruments
have demonstrated sensitivities of greater than 90% [124-126]. In a study performed in
California, the sensitivity, specificity, positive predictive value, and negative predictive
value of diagnosing stroke using LAPSS were found to be 91%, 97%, 86%, and 98%,
respectively [124]. In another study, the sensitivity and specificity of CPSS in diagnosing
stroke was reported as 95% and 54%, respectively [127].
Prehospital notiﬁcation by EMS personnel of in-bound stroke patients shorten
delays from emergency department (ED) arrival until initial neurological assessment and
initial brain imaging, and increases the proportion of patients treated with reperfusion
therapy [119, 128]. In remote geographical areas without nearby stroke facilities, air
medical transport can be used to airlift stroke patients from the ﬁeld to a facility capable
of managing acute stroke patients [129]. Air medical transport reduces transit times,
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thus may enable more rural residents access to thrombolytic therapy [130], and may be
cost effective as well [131, 132].

1.1.8 Role of Specialized Care in Myocardial Infarction and Stroke Care

The creation of cardiac and stroke centers has improved patient outcomes over
the years. One of the key components of specialized care for MI and stroke patients is
prompt treatment, which increases the likelihood of survival [133, 134].

1.1.8.1 Myocardial Infarction Care
Acute MI is frequently characterized by life-threatening complications. As a result,
triage of patients with acute MI to cardiac centers is generally the accepted standard of
care [135]. Unfortunately, availability of this optimal strategy is limited because only
25% of hospitals in the United States have the ability to perform PCI [136].
Percutaneous coronary intervention can only be done in hospitals equipped with a
catheterization laboratory and a specialized team that must be available 24 hours a day
[75].
The AHA and the American College of Cardiology (ACC) have developed
guidelines for the treatment of patients with CAD [7, 137]. Despite the wide availability
of these guidelines, adherence to them in clinical medicine has been shown to be
incomplete, highly variable, and there are frequently missed opportunities to implement
this evidence-based care [138-140]. These missed opportunities may adversely affect
short-, intermediate-, and long-term patient outcomes which potentially contribute to the
high morbidity, mortality, and economic cost resulting from this condition. In order to
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ensure consistent application of the latest evidence–based scientific guidelines in the
treatment of CAD, including MI, the AHA launched the “Get with The Guidelines
Coronary Artery Disease” (GWTG-CAD) program [141] which has been instrumental in
measuring and improving consistency of healthcare for CAD among participating
hospitals in the US [142]. Other programs like the ACC‟s Guidelines in Applied Practice
(GAP) program were also developed for the same purpose [143]. Hospitals participating
in GWTG-CAD have demonstrated improved adherence to national guidelinerecommended therapies compared with non-participating hospitals [142, 144].
Moreover, adherence to guideline-based care has shown improved outcomes after
acute MI [145].
1.1.8.2 Stroke Care
For optimal acute stroke care, it is essential that all stroke patients are
immediately referred to the hospital best equipped to provide the most appropriate
acute stroke care. A stroke unit is a hospital unit or part of a hospital unit that
exclusively or nearly exclusively takes care of stroke patients. The minimum
requirements of stroke centers include 24 hour availability of CT scanning and
neurologists or other stroke physicians, presence of specialized staff, and adherence to
treatment and management guidelines [146]. In a systematic review report, stroke
patients who were treated in a stroke unit had an 18% lower mortality, a 29% lower
dependence for activities of daily living, and a 25% lower need of institutional care
compared to those treated in a general medical ward [147]. In another study, Asplund et
al reported that organized stroke unit care resulted in long-term reductions in death,
dependency, and the need for institutional care in stroke patients compared with
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conventional care [148]. The observed benefits were not restricted to any particular
subgroup of patients or model of stroke unit care. Even when specialist support is
provided, there are substantial differences in management and complications in stroke
patients cared for in stroke units and general wards [149]. These may be responsible for
the more favorable outcomes seen in patients in stroke units compared to those on
general wards. The AHA‟s “Get with The Guidelines stroke” (GWTG-stroke) program
was also developed to ensure consistent application of the latest evidence–based
scientific guidelines in the treatment of stroke. Hospitals participating in the AHA/ASA
GWTG-Stroke program have been associated with rapid and marked improvements in
the quality of care for acute stroke patients during hospitalization [150, 151].
1.1.9 Access to Healthcare
Andersen defines access as the “ability to use health services when and where
they are needed” [152]. Access to care can also be defined as “the timely use of
personal health services to achieve the best health outcomes” [153]. Receiving medical
treatment in a timely fashion can reduce complications, long-term disability, and death
from many conditions, including MI and stroke [154]. Access to healthcare has
considerable effect on health disparities. The large gap in access to health and
healthcare between different groups in developed and developing countries is well
documented [153]. There is significant evidence that access to the healthcare system
varies by socioeconomic factors (such as, race, age, education, income, sex, culture,
ethnicity, and lack of insurance) and geographic location. Individuals with limited or no
access to care experience poor health outcomes, as well as worse quality of care [153].
Although socioeconomic factors and health insurance status are significant and
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powerful predictors of access to healthcare [155], these factors do not explain all of the
racial and ethnic disparities in access to care. Evidence shows that even when
accounting for insurance and income, disparities in access to care still persist [154].
Location of healthcare services is another important dimension of access to
healthcare [156]. Studies reveal the unsurprising fact that utilization of care services
tends to decline as the distance traveled to care increases [157]. This may explain why
urban residents, who are often also wealthier, use services more than their rural
counterparts [158]. Rural residents face travel barriers arising from distance and the
lack of public transportation systems. Distance as a barrier to healthcare is not only
confined to low- and middle-income countries but is a problem in high-income countries
as well. A study of MI patients in the US found that patients living more than 20 miles
away from a hospital were much less likely to visit ambulatory services for follow-up
[159]. Additionally, reports show that MI patients within close proximity to cardiac
centers are more likely to receive cardiac procedures such as PCI compared to those
that are further away from the cardiac centers [160, 161]. In Japan, access to follow-up
care after stroke treatment was considerably influenced by access to suitable
transportation [162]. Location not only influences whether people present for treatment
but also how long they wait before seeking treatment. For instance, a study in Vietnam
found that location was the main determinant of the delay between onset of illness and
presenting for treatment [163]. Transportation barriers to care have also been
associated with reduced compliance to treatment regimens, lower rates of preventive
care, as well as greater difficulties in accessing emergency healthcare [164, 165].
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Despite the fact that most Americans have good access to healthcare that
enables them to benefit fully from the Nation‟s healthcare system, some population
groups face barriers that create difficulties in obtaining basic healthcare services [153].
For instance, rural residents often face barriers to accessing high quality care, such as,
travelling longer distances to reach healthcare delivery sites [166]. Moreover, rural
areas have fewer healthcare resources [156, 166] and yet rural residents report more
chronic conditions (such as, heart disease and diabetes) and are generally described in
poorer health than urban residents [154]. In Tennessee, disparities regarding
geographic access to healthcare in both rural and urban residents have been reported
[167]. In a study carried out in East Tennessee, Pedigo and Odoi reported disparities in
geographic accessibility to emergency stroke and MI care [22]. Therefore, timely
geographic access to appropriate care centers for conditions, such as MI and stroke,
that require time sensitive treatments is important for improving patients‟ health
outcomes and reducing mortality.
1.1.10 Burden of Heart attack and Stroke
1.1.10.1 Incidence, Prevalence and Mortality
1.1.10.1.1 Myocardial Infarction

Coronary heart disease, including heart attack, is the leading cause of death in
the world with more than 60% of the global burden being shouldered by developing
countries [1]. Today, approximately 3.8 million men and 3.4 million women worldwide
die each year from CHD [1]. According to the Global Burden of Disease Study, of the
6.2 million global deaths from CHD in 1990, 3.5 million deaths occurred in the
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developing countries. Future projections estimate that these countries will account for
7.8 million of the 11.1 million deaths due to CHD in 2020 [168]. Coronary heart disease
is the single most common cause of death in Europe, accounting for 1.92 million deaths
each year and is also the most common cause of death in the European Union (EU)
accounting for over 741,000 deaths each year. The EU is currently composed of 27
sovereign Member States: Austria, Belgium, Bulgaria, Cyprus, the Czech Republic,
Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Italy, Latvia, Lithuania,
Luxembourg, Malta, the Netherlands, Poland, Portugal, Republic of Ireland, Romania,
Slovakia, Slovenia, Spain, Sweden, and the United Kingdom (UK). Approximately 1.4
million people older than 35 years in the UK have had MI, (970,000 men and 439,000
women). In 2006, CHD accounted for about 94,000 deaths in the UK; that is about 1 in
5 deaths among men and 1 in 7 deaths among women [169]. About 70,000 heart
attacks occur in Canada annually, accounting for over 16,000 deaths annually [170]. In
China, CHD is also the leading cause of morbidity and mortality in adults. The
prevalence of CHD in China in 2003 was 4.6 per 1,000 for all ages [171].

Coronary heart disease is the leading cause of death in the US [21] with 17.6
million Americans having the condition [172]. In 2007, 1 out of every 6 deaths in the US
was due to CHD and MI accounted for about 132,968 deaths [21]. On average, a heart
attack occurs in the US every 34 seconds. Currently, an estimated 8.5 million people in
the US have had a heart attack, and about 610,000 new attacks and 325,000 recurrent
attacks are diagnosed annually [5]. In Tennessee, CHD is also the leading cause of
death and accounted for about 55% of all the cardiovascular deaths in 2004 [6] as well
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as 25.8% of total deaths in 2006 [4]. The prevalence of CHD in adult Tennessee
residents (≥ 18 years) in 2008 was 5.8% [173].

1.1.10.1.2 Stroke
Approximately 15 million people worldwide suffer a stroke annually. Of these, 5
million die and another 5 million are permanently disabled [1]. Stroke accounts for about
10% of all deaths in developed countries. Stroke is a global problem that is not only
limited to the developed or industrialized countries but also affects developing countries.
About 85% of all stroke deaths are registered in low- and middle-income countries
[174].

In Europe and the EU, stroke is the second most common cause of death

accounting for 1.24 million and 508,000 deaths, respectively, each year [169]. In the
UK, it is estimated that about 111,000 new stroke cases occur accounting for about
53,000 deaths annually [175]. Stroke is the third leading cause of death in Canada,
accounting for about 14,000 deaths annually. An estimated 50,000 stroke cases occur
in Canada each year, and about 300,000 Canadians are living with the effects of stroke
[169]. Approximately 8 million stroke incidences [176] are said to occur in China
annually and more than 1.5 million people die from stroke, three times as many as die
from CHD [177].
Stroke is the third leading cause of death and the leading cause of disability in
the US. Approximately 6.4 million people in the US have had a stroke [172]. It is also
estimated that 795,000 people experience a new or recurrent stroke annually. This
implies that on average, every 40 seconds an individual suffers a stroke in the US [21].
In 2007, the overall stroke mortality risk in the US was 42.2 per 100,000 or
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approximately 1 out of every 18 deaths [21]. In Tennessee, stroke is the third leading
cause of death and accounted for 6% of total deaths in 2006 [6]. Tennessee has one of
the highest stroke mortality risks in the country and the state‟s overall mortality risk is
usually higher than the national rate. For example, the age-adjusted stroke mortality risk
for Tennessee for the period 2005-2007 was 58.1 per 100,000, while that of the whole
country was 44.1 per 100,000 persons [21]. Additionally, about 20,000 hospitalizations
for stroke were recorded each year between 1997 and 2004 in Tennessee [6]. Three
percent of the 2009 Center for Disease Control/Behavioral Risk Factor Surveillance
System (CDC/BRFSS) survey respondents from Tennessee reported to have had a
stroke [178].
1.1.10.2 Economic Burden
1.1.10.2.1 Myocardial Infarction

Cardiovascular disease is of great economic burden to the healthcare system
worldwide. The economic impact of CVD is felt as: the healthcare costs to the individual,
family, and government; and costs to the country due to lost productivity [1]. Coronary
heart disease is not only the leading cause of death, but is also an important source of
disability. Cardiovascular disease accounts for 10% of Disability-adjusted life years
(DALYs) in low- and middle-income countries, and 18% in high-income countries [1].
Disability-adjusted life years is a measure of overall disease burden, expressed as the
number of years lost due to early death or disability [179]. This is exacerbated in the
developing world where cardiovascular disease affects a high proportion of working-age
adults [180]. The estimated annual cost of CHD to the EU economy is about €49 billion.
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Of this cost, 48% is due to direct healthcare costs (which include the cost of physicians
and other health professionals, acute- and long-term care, medications and other
medical durables), 34% to lost productivity (due to morbidity and mortality), and 18% to
the informal care of CHD patients [181]. In 2006, CHD cost the UK, France, Austria,
and Germany healthcare systems about €4.5 billion, €2 billion, 3.5 million, and €8
billion, respectively, in healthcare costs [181]. Cardiovascular disease costs the
Canadian economy more than $22.2 billion every year in physician services, hospital
costs, lost wages and decreased productivity [170]. In China, annual direct costs are
estimated at €30.76 billion or 4% percent of gross national income [180].

The estimated total direct and indirect cost of heart disease in the US for 2007
was $177.5 billion. Direct costs accounted for about 46% of the total cost while indirect
costs accounted for about 54% [21]. Heart disease is expected to cost Tennessee an
estimated 6.75 billion US dollars in both direct and indirect costs in 2011 [182].

1.1.10.2.2 Stroke

Stroke is a leading cause of morbidity and mortality in the world, imposing an
enormous economic burden on individuals, family, and society. The global burden of
stroke is projected to rise from 38 million DALYs in 1990 to 61 million DALYs in 2020
[1]. Annually, stroke costs the EU economy an estimated €38 billion, of which, about
49% is due to direct healthcare costs, 23% to lost productivity, and 29% to the informal
care of stroke patients [181]. In 2006/07, stroke cost the UK healthcare system about
£4.5 billion. Health and social care costs accounted for more than half (56%) of this.
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Production losses, and cost of informal care of stroke patients accounted for 21% and
22%, respectively [175]. Stroke costs the Canadian economy about $3.6 billion annually
in physician services, hospital costs, lost wages, and decreased productivity [170].

The 2007 total direct and indirect cost of stroke in the US was estimated at $40.9
billion. Direct costs accounted for about 62% of total costs, while the remaining 38%
was due to indirect costs [21]. The 2011 total direct and indirect cost of stroke in
Tennessee is estimated at $1.38 billion [182]. Direct costs are expected to account for
about 39% of total costs, while the remaining 61% will be due to indirect costs.

1.1.11 Temporal Trends
In recent decades, most developed countries have witnessed declines in CVD
mortality, including CHD and stroke. However, other parts of the world show different
patterns, including high rates of CVD mortality in Eastern Europe that continue to rise
and a threatening epidemic of CHD and stroke emerging in developing countries [183].
The increasing trend of CVD burden observed in developing and transitional countries is
partly due to increasing longevity, urbanization, and lifestyle changes [1]. The factors
essential for decreasing trends in mortality from CHD and CVD, as seen in developed
countries are variable and include favorable changes in risk factor exposure, such as
decreased smoking, improvements in diet and physical exercise, and better control of
hypertension and other risk factors [168, 184]. Advances in treatment and management
of patients with CHD and stroke may also account for a substantial proportion of the
favorable trends [17]. Despite the observed decline in CVD mortality in recent decades,
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the WHO predicts that by 2030, CVD will account for about 23.4 million deaths globally
[185].
1.1.11.1 Myocardial Infarction
Mortality from CHD has been declining in the US and Japan since the early
1970s and in Western Europe since the mid- to late 1970s. However, in some countries
in central and Eastern Europe, CHD death risks have been rising. For instance, death
risks for men aged less than 65 years living in Finland and the UK declined by 37% and
42%, respectively, between 1994 and 2004, but rose by 57% for men of the same age
living in Albania and by 19% for men living in the Ukraine. For women aged under 65
years living in Finland and the UK, mortality risks fell by 35% and 49%, respectively, but
rose by 46% and 19% for women living in Albania and Ukraine, respectively [181]. In
the EU, age-adjusted mortality risks from CHD for men rose from 146 per 100,000
persons in 1965–69 to 159 in 1975–79 but declined thereafter to 99.6 in 1995–97. The
pattern was similar in women, with a peak at 69 in 1975–79 followed by a decline to 45
in 1995–97 [186]. In the UK, the percentage decline in age-adjusted CHD mortality risks
between the periods 1965-1969 versus 1995-1998 was 41% for men and 38% for
women. In the Russian Federation, the age-adjusted CHD mortality risk in men
increased from 304 per 100,000 persons in the period 1985-1989 to 330 in the period
1995-1998. However, for women in the Russian Federation, the age-adjusted CHD
mortality risk decreased from 163 per 100,000 persons to 154 in the same time period
[186]. In addition, results from the Monitoring of trends and determinants in
Cardiovascular diseases (MONICA) project showed that the incidence and case fatality
of CHD were falling rapidly in most Northern, Southern, and Western European
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countries but not falling as fast in the East and Central Europe populations [181]. The
decrease in age-adjusted CHD mortality risks from the late 1960s to mid 1990s were
very substantial in Japan. A 29% and 36% decline in age-adjusted CHD mortality risks
was observed for both Japanese men and women, respectively, during this time period.
In Canada, a 60% and 59% decline in age-adjusted CHD mortality risks was observed
for the period 1965-1969 versus 1995-1997 in men and women, respectively [186].
Additionally, in Canada the age- and sex-adjusted in-hospital case fatality rate for acute
myocardial infarction declined from 14.5% in 1994 to 9.7% in 2004 [15]. Figures 1.1 and
1.2 show trends in age-adjusted mortality risks from CHD in men and women between
1965 and 1997 [186].
In the US, recent evidence suggests that the decline in CHD mortality since the
late 1960s has slowed especially in specific subgroups defined by socioeconomic
status, race or ethnicity, and region [183]. For instance, early in the decline of CHD and
stroke, CVD death risks in all major demographic groups declined in parallel. However,
since the mid-1980s, the documented trends in CHD have differed across race/sex
subgroups with the rates of CHD mortality decline being slow in black men and women
compared to their white counterparts [187-189]. The age-adjusted CHD mortality risks
decreased at >3% per year for the 20-year period between 1970 and 1990. However,
for the 7-year period between 1990 and 1997, CHD mortality declined at a rate of 2.7%
[183]. Between 1990 and 1994, age-adjusted mortality from CHD among people 35
years of age or older declined by 10.3%; the rate of decline was highest for white men
(2.9% per year) and lowest for black women (1.6% per year) [190]. Additionally,
Rosamond et al reported a decline in mortality due to CHD of 28% for men and 31% for
35

Figure 1.1: Trends in Age-adjusted Mortality Risks from CHD in Men of All Ages from the EU, Eastern
European countries, US, and Japan, 1965 to 1997
Source: Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular
diseases in Europe and other areas of the world. Heart 2002;88(2):119-24
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Figure 1.2: Trends in Age-adjusted Mortality Risks from CHD in Women of All Ages from the EU, Eastern
European countries, US, and Japan, 1965 to 1997
Source: Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular
diseases in Europe and other areas of the world. Heart 2002;88(2):119-24
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women among 35-74 year old residents of four geographically and ethnically diverse
communities in the US from 1987-1994 [191]. In the same study, the decrease in the
age-adjusted case fatality rate was 4.1% per year for men and 9.8% per year for
women. However, there was no evidence of a decline in the case fatality rate among
blacks hospitalized for myocardial infarction. The Minnesota Heart Survey (MHS) study
reported that the crude 28‐day case‐fatality of MI decreased from 18% in 1970 to 13%
in 1985 among men and from 27% in 1970 to 18% in 1985 among women [192]. A
follow-up study reported a decline in the age‐adjusted case‐fatality from 13% in 1985 to
11% in 1990, and to 7% in 1995 for men; whereas for women, a decline from 18% in
1985 to 12% in 1990, and to 10% in 1995 was also reported [193].
Despite the substantial decline in the CHD mortality observed, the incidence of
MI is said not to have declined as much as the mortality, and the trends vary by time
and among studies. In the MHS study, the age-adjusted incidence for definite MI was
found to be similar in 1970 and 1980 [194]. During the period of 1985-1997, the
incidence of hospitalized definite MI decreased by about 10% [193]. The Worcester
Heart Attack study reported a slight increase in initial and recurrent MI between 1975
and 1981 [195]. However, after this time period, a decrease in MI rates was observed
through 1995 [196, 197]. The Atherosclerosis Risk in Communities (ARIC) study
reported an increased incidence (7.4% per year) of hospitalization for MI from 19871994 [191]. In Tennessee, a 21% decline in the age-adjusted mortality risk from
diseases of the heart was recorded between 1996 and 2005 [6].
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1.1.11.2 Stroke
Like CHD, stroke mortality risks have declined in most developed countries [198,
199]. Although the incidence of stroke in developed countries is declining, largely due to
efforts to reduce risk factors (such as, high blood pressure and smoking), the overall
rate of stroke remains high due to the aging of the population [200]. A decline in stroke
incidence has been reported in the United States [201], Asia [202], and Europe [203].
During the 1950s and early 1960s, most developed countries were characterized by
increasing trends in stroke mortality. However, since the mid 1960s, stroke mortality
rapidly declined for the next 2 decades [204, 205]. On the contrary, most eastern
European countries, Portugal and Yugoslavia showed increasing trends in mortality
from stroke [204-206]. In the Russian Federation, age-adjusted mortality risks for stroke
in both men and women increased between the periods 1985-89 and 1995-98. The
Russian rates of 204/100,000 men and 151/100,000 women for stroke recorded
between 1995 and 1998 were among the highest registered worldwide [186]. Between
1994 and 2004, the mortality risks for men aged below 65 years decreased by 43% for
those living in Germany and by 28% for those in the UK. Similarly, the mortality risks for
women aged 65 years and below living in Germany decreased by 37% and by 28% for
those in the UK. However, for women living in Albania, the mortality risks increased by
15% [181]. In the EU, age-adjusted mortality risk from stroke for men declined from 103
per 100,000 persons in 1965–69 to 87 in 1975–79 and declined further to 46 in 1995–
97. A similar trend was observed for women, declining from 83 per 100,000 persons in
1965-69 to 36 in 1995-97 [186]. In Canada, a decline of 58% for men and 59% for
women was observed in the age-adjusted mortality risk for stroke between the time
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period of 1965-69 and 1995-97. In Japan, the age-adjusted mortality risk for stroke in
men decreased from 228 per 100,000 persons in 1965-67 to 61 in 1995-97 whereas
that for women decreased from 150 per 100,000 persons to 38 in the same time periods
[186]. Figures 1.3 and 1.4 show trends in age-adjusted mortality risks from stroke in
men and women from 1965 to 1997 [186].
Like many other developed countries, stroke mortality risks in the US have
declined in the past decades. However, substantial geographic, racial, and sex
differences in the pattern of the decline of stroke mortality have been reported [207]. For
instance, the age-adjusted mortality risks from stroke for men declined from 78 per
100,000 persons in 1965–69 to 29 in 1995–97. A similar trend was observed for women
with a 59% decline in the age-adjusted mortality risks between 1965-69 and 1995-97
[186]. Additionally, from 1997 to 2007, the annual stroke mortality risk decreased by
34.3%, and the actual number of stroke deaths declined by 18.8% [21]. Decline in the
incidence of stroke has also been reported in the US [201]. In a Framingham Study, the
age-adjusted incidence of a first stroke in males declined from 7.6 per 1,000 persons in
1950-1977 to 5.3 in 1990-2004 whereas that of women declined from 6.2 to 5.1 in the
same time period [200]. The earliest study looking at trends in stroke incidence reported
a decrease of 45% in the average annual incidence of stroke between 1945-1949 and
1975-1979 [208]. Several other studies; including the Honolulu Heart Program [209] and
studies from China [176], Denmark [210], Australia [211], Japan [212], Finland [213],
England [214], New Zealand [215], and France [216] have reported decreasing or stable
incidences mostly attributed to reduction in risk factors over time. Studies have also
reported a temporal trend toward decreasing severity and disability from stroke, which
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Figure 1.3: Trends in Age-adjusted Mortality Risks from Stroke in Men of All Ages from the EU, Eastern
European countries, US, and Japan, 1965 to 1997

Source: Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular
diseases in Europe and other areas of the world. Heart 2002;88(2):119-24
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Figure 1.4: Trends in Age-adjusted Mortality Risks from Stroke in Women of All Ages from the EU,
Eastern European countries, US, and Japan, 1965 to 1997

Source: Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from cardiovascular and cerebrovascular
diseases in Europe and other areas of the world. Heart 2002;88(2):119-24
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may be attributed to the increasing sensitivity of imaging techniques such as CT and
MRI for identifying stroke thus enabling quick treatment of patients and consequently
leads to better outcomes [212, 214, 217]. Although Tennessee has one of the highest
stroke mortality risks in the country, the age-adjusted mortality risk from stroke
decreased by 23% between 1996 and 2005 [6].
1.1.12 Spatial Patterns
Identifying spatial patterns of disease distribution can help identify possible
determinants of disease occurrence. Such factors include risk behaviors, socio-cultural
factors, environmental factors, and availability of healthcare resources. Considerable
geographic disparities in CVD incidence and mortality have been documented all over
the world [183, 218-220]. The highest risks of cardiovascular mortality have been
reported in Eastern Europe, Central Asia, the Middle East, and North Africa [221].
Geographic disparities exist between countries as well as within countries. Urban-rural
differences in the distribution of cardiovascular disease have also been documented
with higher prevalence of coronary heart disease being seen in rural versus urban
populations [222, 223]. Geographic comparisons of disease incidence and mortality
risks within countries and between countries are valuable for identifying high-risk
populations and for generating new hypotheses for defining preventive programs.
Although the underlying causes of disparities in stroke and MI mortality are not fully
understood, variation in the prevalence of contributing risk factors (such as: smoking,
hypertension, hyperlipidaemia, diabetes, overweight; as well as socio-economic factors;
lifestyle variables such as diet, alcohol use, physical activity; medical care; genetic
factors; and environmental conditions) has been implicated as one of the causes for
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these disparities [224]. Disparities in awareness as well as access to information and
health services are also responsible for the variations in stroke and MI mortality risks
[20].
In order to assess the degree of geographical health disparities, small area
analyses are recommended because analyses performed at large geographic levels
have been shown to mask the underlying patterns of disease thus lead to distortion of
the underlying spatial patterns [225]. Secondly, small area data are more likely to be
homogenous with respect to population characteristics, thus provide more accurate data
for assessing the association between population characteristics and disease. In the
US, census tracts have been shown to be good proxies of natural neighborhoods due to
their small size and homogenous nature of the population characteristics within them
[226].
1.1.12.1 Myocardial Infarction
In Europe, CHD death risks are generally higher in Central and Eastern than in
Northern, Southern and Western Europe [181]. Sans et al reported a clear north-east to
south-west gradient in CHD mortality with the lowest risks for both men and women in
France, Spain, Switzerland, and Italy. The highest risks were observed in Central and
East European countries such as Ukraine, Bulgaria, or the Russian Federation [219].
The mortality risk for men aged less than 65 years living in Ukraine was 14 times higher
than those living in France and for women it was 25 times higher. In addition, the
mortality risk for men aged less than 65 years living in Ireland was 1.6 times higher than
those in Italy whereas for women it was 1.8 times higher [181]. Regional variations
within countries have also been recorded [218, 227, 228]. A north-south gradient has
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been reported in Britain with higher CVD mortality risks in the north compared to the
South [228]. In France, mortality risks due to ischemic heart disease showed a northsouth gradient [227]. In India, high CVD mortality risks among middle-aged adults have
been observed in Andhra Pradesh, Tamil Nadu, Punjab and Goa whereas low mortality
risks have been observed in sub-Himalayan states of Nagaland, Meghalaya, Himachal
Pradesh and Sikkim [222] . The CHD mortality risk in China is higher in northern China
(Beijing) than in southern China (Shanghai and Guangzhou) and also higher in urban
than rural areas [229, 230]. Geographic disparities in CHD have also been reported in
Canada [231, 232] and Australia [233].
In the US, substantial geographic disparities in CHD incidence and mortality have
also been documented. Coronary heart disease mortality in the United States has
revealed a west-to-east gradient with clustering in some states [183]. For example,
strong clusters of high CHD mortality risks especially among women have been
observed in Mississippi Delta, Appalachia, the Ohio River Valley, the Piedmont areas of
Georgia, South Carolina, and North Carolina [183]. Most areas currently observed with
high CHD mortality are frequently characterized as rural and poor. Additionally, even
within a single population subgroup such as among Native Indians within the US,
geographic variations in cardiovascular disease risk exist depending on the State of
residence [234]. According to the data from 2009 BRFSS survey of the CDC, the
highest MI prevalence was in West Virginia (6.5%) and Kentucky (5.9%) whereas the
lowest prevalence was in the District of Columbia (1.9%) [21]. In Tennessee, high CHD
mortality risks have been observed in the Appalachian counties compared to other
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counties in the state. These counties lie in the stroke belt and have higher mortality risks
of both CHD and stroke.
1.1.12.2 Stroke
Globally, the highest age- and sex-adjusted mortality risks from stroke have been
reported in Eastern Europe, north Asia, central Africa, and the south Pacific whereas
the lowest risks have been reported in Western Europe and North America [235]. In
Europe, lower stroke mortality risks have been observed in the center of Western
Europe with the lowest mortality risks in Switzerland, France, Norway, Spain, the
Netherlands, and Italy. Higher mortality risks have been observed in countries in the
Central and Eastern part as well as some Mediterranean countries including Greece,
Portugal, and certain regions in Southern Spain and Italy [236]. The stroke mortality risk
for men less than 65 years of age living in the Russian Federation is said to be 20 times
higher than those in Switzerland while that of women of the same age is 15 times higher
[181]. Considerable within-country variations in stroke mortality risks have been
observed in Italy, Spain, Portugal, and the UK [236]. In the UK [228] and Finland [237],
the northern parts of both countries have a higher incidence of stroke than the south.
Within Canada, an east-west gradient in CVD mortality risks has been observed with
Atlantic Canada having consistently higher risks than Western Canada [238].
Cardiovascular disease mortality risks in 1995 were highest for men and women in
Newfoundland and lowest in British Columbia. However, regional differences seem to
be more notable with respect to mortality risks from acute MI than to those from stroke
[238]. A north-south gradient with significantly higher incidence and mortality risks of
stroke in the north compared with the south have been observed in China [177, 239,
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240]. In most countries, such as the US [241], Canada [242], Bulgaria [243], and
Portugal [244], higher stroke incidence or mortality risks have been observed in rural
residents compared to urban residents. However in China, some reports show higher
stroke incidence, prevalence and mortality risks in the urban areas compared to rural
areas [177, 240].
In the US, stroke incidence and mortality risks are highest in some south-eastern
states, referred to as the „stroke belt [245]. This area includes the eight southern states
of North Carolina, South Carolina, Georgia, Tennessee, Mississippi, Alabama,
Louisiana, and Arkansas. The average stroke mortality in the stroke belt is
approximately 20% higher than in the rest of the nation [21]. Even within the states
(both in the stroke belt and for the rest of the nation), stroke mortality risks vary between
regions [246]. For instance, a “buckle” of the stroke belt has been identified in the
coastal plain of North Carolina, South Carolina, and Georgia, where the stroke mortality
risk is much higher (about 40%) than for the remainder of the nation [21, 247]. Results
from the 2009 survey of the CDC/BRFSS, showed that the highest stroke prevalence
was in Alabama and Oklahoma (3.9%) and the lowest was in Colorado (1.4%) [178]. In
Tennessee, high stroke mortality risks have been observed in the Appalachian counties
that lie within the „stroke belt‟.
1.1.13 Myocardial Infarction and Stroke Risk Factors

Many risk factors are associated with both CHD and stroke [248]. However, the
major risk factors are those that meet the following criteria: a high prevalence in many
populations; a significant independent impact on the risk of coronary heart disease or
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stroke; and their treatment and control result in reduced risk of these conditions [1]. The
risk factors are divided into modifiable and non-modifiable risk factors. Modifiable risk
factors include hypertension (high blood pressure), diabetes, dyslipidemia (high blood
cholesterol and triglycerides), smoking, alcohol consumption, poor diet, physical
inactivity, stress, obesity, and socioeconomic status. Non-modifiable risk factors include
age, sex, race/ethnicity, and genetic factors.

1.1.13.1 Modifiable Risk factors
1.1.13.1.1 Hypertension

Hypertension, also known, as high blood pressure (HBP) is defined as persistent
systolic blood pressure (SBP) of at least 140 mmHg and/or diastolic blood pressure
(DBP) of at least 90 mmHg, or blood pressure that is controlled to guidelinerecommended levels using antihypertensive medication [5, 249]. Blood pressure
normally rises with age. Diastolic blood pressure and SBP are associated with
cardiovascular risk in people aged up to 50 years, whereas, above this age, SBP is a far
more important predictor [1]. High blood pressure means that the heart is pumping
harder to move blood through the body thus causing overstretching of the arteries.
Overtime, the overstretching creates weak points in the vessels thus making them more
prone to ruptures. Overstretching may also cause tiny tears in the blood vessel walls
that leave scar tissue. These tears and the scar tissue may trap debris such as
cholesterol, plaque or blood cells traveling in the bloodstream. Cholesterol and plaque
buildup may cause narrowing or blockage of the arteries thus causing heart attack or
stroke. Trapped blood cells can also form clots which may narrow or block the arteries.
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High blood pressure is a major independent predictor of cardiovascular events
and accounts for about 60% of the population attributable risk of stroke [250, 251].
Additionally, an increment of 20 mmHg SBP doubles the risk of stroke in individuals
aged 40–69 years [252]. In one study, the risk of a fatal coronary event was seen to
double with each increase in SBP of 20mmHg (or 10mmHg in DBP) [252]. In the same
study, it was observed that the risk of adverse outcomes increased with age, such that
for any given SBP, the risk of fatal coronary artery disease was 16-fold higher for
persons 80-89 years of age than for those 40-49 years of age. Several randomized
controlled trials have demonstrated that reduction in mean blood pressure reduces the
risk of cardiovascular events [253-256]. One study demonstrated a 35-44% reduction in
the incidence of stroke by lowering the blood pressure [254]. Despite the observed
improvements in hypertension treatment, awareness and control rates, prevalence of
hypertension continues to increase in the general US population. For example, the
prevalence of hypertension increased from 24.4% in 1988-1994 to 28.9% in 1999-2004
[257]. The WHO estimates that about 11% of all disease burden in developed countries
is due to high blood pressure, and over 50% of CHD and about 75% of stroke burden is
due to hypertension [258]. In 2008, 32% of men and 29% of women in England, and
34% of men and 31% of women in Scotland had hypertension [258]. Nineteen percent
of Canadian adults have hypertension [170].

Hypertension is one of the most prevalent modifiable risk factors for MI and
stroke, and affects at least 65 million people in the United States [5]. On average, 1 in 3
US adults has hypertension [259]. According to the 2007 BRFSS study, the prevalence
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of hypertension in adults (≥18 years) ranged from 19.7% in Utah to 33.8% in Tennessee
[5]. Furthermore, the prevalence of hypertension in Tennessee increased from 26.8% in
1995 to 33.8% in 2007 with the Upper Cumberland region registering the highest
prevalence [173]. The prevalence of hypertension in the US is higher among men
compared to women under age 55, while women have higher prevalence after age 55
[5]. Blacks also have a higher prevalence than whites [5].

1.1.13.1.2 Diabetes Mellitus
Diabetes mellitus is a condition that develops when the body either does not
make enough insulin (type 1) or does not efficiently use the insulin it makes (type 2), a
condition known as insulin resistance [25]. Type 2 diabetes mellitus accounts for more
than 90% of all diagnosed adult diabetes cases in the US [260]. Patients with diabetes
mellitus are at high risk for MI [261] and ischemic stroke, and suffer from a high stroke
morbidity and mortality burden [262]. Approximately one third of all acute stroke patients
are diabetic, and diabetes is associated with poor outcomes in acute stroke patients
[263]. Diabetes affects more women than men, and it‟s risk is higher among blacks,
Hispanics, and Native American people compared to whites [25]. Diabetes doubles
CVD risk in men and triples it in women [264]. Diabetes remains a major independent
CVD risk factor even when all other risk factors such as, advancing age, hypertension,
cigarette smoking, and hypercholesterolemia, are adjusted for. Diabetics have a 2–6
fold increased risk for stroke [265, 266] and 3 fold increased risk for MI [261]. About
65% of people with diabetes mellitus die of heart disease or stroke [5].
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The prevalence of diabetes in Europe in 2003 was 7.8% with about 48 million
adults (20-79 years) living with diabetes. Currently, the prevalence in Europe is highest
in Malta (7.6%) and the Czech Republic (7.2%) [181]. In Canada, 6.6% of the
population aged ≥20 years have diabetes [170]. Predictions are that in China, diabetes
will increase from 1.4 to 2.4% between 1995 and 2025, whereas in India, the equivalent
figures are from 2.1 to 3% [169]. Diabetes is the seventh leading cause of death in the
United States and affects about 26 million Americans. The prevalence of diabetes was
estimated at 8.3% in 2010 [267]. The incidence of diabetes in the US tripled from 5.6
million in 1980 to 18.1 million in 2008 [268]. In Tennessee, the prevalence of diabetes
increased from 6.0% in 1999 to 10.4% in 2008 with Sullivan region having the highest
prevalence [173].
1.1.13.1.3 High Cholesterol
Cholesterol, a natural waxy substance, occurs in all body cells and is one of the
several types of fats (lipids) that circulate in the bloodstream. At healthy levels,
cholesterol is an essential component of cells and blood and is used to form cell
membranes as well as make some hormones [25]. Triglycerides are fats that also
circulate in blood and together with cholesterol are called plasma lipids. High levels of
cholesterol (> 240 mg/dL) and triglycerides (> 150 mg/dL) in the blood lead to buildup of
fatty deposits in the blood vessel walls which may restrict blood flow thus predisposing
to heart attack and stroke. There are two types of cholesterol, high density lipoprotein
(HDL), also known as "good" cholesterol, and low density lipoprotein (LDL), also known
as "bad" cholesterol. High levels of one type or deficiency of another predisposes to
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coronary heart disease, heart attack or stroke. High density lipoprotein helps keep the
LDL from getting lodged into the artery walls, and helps prevent atherosclerosis. A
healthy level of HDL may also protect against heart attack and stroke, while low levels
of HDL (less than 40 mg/dL for men and less than 50 mg/dL for women) have been
shown to increase the risk of heart disease [269].
High blood cholesterol is one of the major modifiable risk factors for coronary
heart disease, heart attack and stroke [269]. The risk of CHD rises with increased
amount of blood cholesterol and this risk is accelerated by presence of other risk factors
such as, high blood pressure, diabetes, and tobacco smoke. Although the importance of
high total cholesterol as a risk factor for stroke is undeniable, there is still a debate
about its role as a risk factor. Several studies have demonstrated the association
between high total cholesterol levels with risk of stroke [270-272], whilst others found no
clear associations [273-276]. The association between LDL and ischemic stroke has
also been reported inconsistently [271, 276]. However, there is evidence of increased
risk of ischemic stroke with low levels of HDL [272, 277-279]. Despite the inconsistent or
weak association between cholesterol and stroke, a decrease in cholesterol
concentrations has been observed to reduce the incidence of stroke in high-risk
populations [280]. Whereas the association between high total cholesterol and risk of
stroke remains unclear as a result of conflicting results reported in the literature, there is
evidence of an association between increased blood cholesterol levels and increased
risk of coronary heart disease [281]. Moreover, a 10% decrease in total cholesterol
levels of the population is estimated to reduce the incidence of CHD by 30% [282].
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According to the WHO, about 60% of CHD and around 40% of stroke burden in
developed countries is due to high total blood cholesterol levels [181]. About 57% of
men and 61% of women in the United Kingdom; and an estimated 10 million Canadians
have high blood cholesterol levels [169]. Approximately 50% of the adults (≥20 years) in
the US have total cholesterol concentrations of at least 200 mg/dL [283], the level
considered “borderline-high risk” by the National Cholesterol Education Program expert
panel [284]. The 2009 data from the BRFSS survey showed that an estimated 37.5% of
the adults in the US had been told that they had high blood cholesterol with the highest
percentage in South Carolina (41.8%) and the lowest in Tennessee (32.9%) [21]. In
2007, Madison had the lowest prevalence (22.5%) while East region had the highest
(41.4%) among the health department regions of Tennessee. The prevalence of high
cholesterol in Tennessee increased from 27.5% in 1995 to 34.2% in 2007 [173].
1.1.13.1.4 Cigarette Smoking
Smoking increases blood pressure, decreases exercise tolerance, and increases
the tendency for blood to clot. Toxins in the blood, from smoking cigarettes, contribute
to the development of atherosclerosis. Inflammation of the artery wall and the
development of blood clots can obstruct blood flow and cause MI or stroke. Cigarette
smoke also contains nicotine and carbon monoxide which lower oxygen levels in blood
cells causing the heart to pump faster in order to keep the oxygen supply adequate.
Tobacco smoke decreases the amount of HDL cholesterol in the blood thus increasing
the risk of heart disease. Cigarette smoking increases the risk of CHD and stroke by
itself, however, the synergistic effect with other risk factors, such as hypertension and
diabetes, greatly increases the risk of both CHD and stroke [285]. Smoking nearly
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doubles the risk of ischemic stroke [5, 248] and also accounts for about 12-14% of all
stroke deaths in the United States [286], with the risk being strongly dose-related [287].
The risk of dying from CHD is 2-3 times higher in people who smoke cigarettes
compared to those that do not smoke [5]. Additionally, the risk for stroke and CHD is
much higher in smokers who are below 50 years of age. Furthermore, women who use
oral contraceptives in addition to cigarette smoking have increased risk of stroke and
CHD as compared to those that do not take oral contraceptives [285].
Exposure to environmental tobacco smoke (secondhand smoke) has also been
identified as a risk factor for heart disease [288] as well as stroke [289]. Short exposure
to secondhand smoke has immediate adverse effects on the cardiovascular system,
interfering with the normal functioning of the heart, blood, and vascular systems in ways
that increase the risk of heart attack. Studies have shown that non-smokers who are
exposed to secondhand smoke have a 25-30% increased risk of CHD [290] . An
estimated 126 million children and nonsmoking adults were exposed to secondhand
smoke in the US between 1999 and 2002 [21]. Enactment of laws enforcing smoke-free
workplaces and public places have had a significant positive impact on reduction of
exposure to secondhand smoking. For example, the percentage of the US population
exposed to secondhand smoke declined from 52.5% in 1999-2000 to 40.1% in 20072008 [21].
Tobacco use kills 5.4 million people a year and accounts for 1 in 10 adult deaths
worldwide. The WHO estimates that by 2020, tobacco is expected to be the single
greatest cause of death and disability worldwide, accounting for about 10 million deaths
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per year [169]. Annually, smoking kills over 1 million people in Europe (453,000 from
CVD) and about 654,000 people in the EU (183,000 from CVD) [181]. In Canada, 19%
of the population smoke, and 14.5% of heart disease and stroke deaths are attributed to
smoking [169].
Cigarette smoking is the most important modifiable risk factor contributing to
premature morbidity and mortality in the US, accounting for approximately 443,000
deaths annually [291]. In 2009, an estimated 46.6 million (20.6%) of US adults were
cigarette smokers; of these, 36.4 million (78.1%) smoked every day, and 10.2 million
(21.9%) smoked on some days. Men had a higher (23.1%) prevalence of smoking
compared to women (17.9%) [291]. In the same year, among adults (≥18 years), West
Virginia had the highest percentage (25.5%) of cigarette smokers and Utah the lowest
(9.8%) [21]. Additionally, the percentage of US adults (≥18 years) who were cigarette
smokers declined from 24.1% in 1998 to 20.6% in 2009. However, the percentage of
smokers did not change significantly from 2005 to 2009 [291]. In 2008, the prevalence
of cigarette smoking among adults (≥18 years) in Tennessee was 23.1%, however,
there was no significant change in prevalence over the period 1999 to 2008 [173].
1.1.13.1.5 Obesity and Overweight
Obesity as defined by the WHO is having a body mass index (BMI) of 30 or more
while overweight is having a BMI of 25 to 29.9 (Table 1.1). Body mass index is a simple
index of weight-for-height that is commonly used to determine whether one has a
healthful or unhealthful percentage of total body fat [292]. It is calculated by dividing the
individual‟s weight in kilograms by the square of the height in meters (kg/m 2). The BMI
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Table 1.1: International Classification of Adult Underweight, Overweight and
Obesity Using Body Mass Index

BMI (kg/m2)

Classification

Principal Cut-off Points

Additional Cut-off Points

Underweight

<18.50

<18.50

Severe thinness

<16.00

<16.00

Moderate thinness

16.00 - 16.99

16.00 - 16.99

Mild thinness

17.00 - 18.49

17.00 - 18.49

Normal range

18.50 - 24.99

18.50 - 22.99;
23.00 - 24.99

Overweight

≥25.00

≥25.00

Pre-obese

25.00 - 29.99

25.00 - 27.49;
27.50 - 29.99

Obese

≥30.00

≥30.00

Obese class I

30.00 - 34.99

30.00 - 32.49;
32.50 - 34.99

Obese class II

35.00 - 39.99

35.00 - 37.49;
37.50 - 39.99

Obese class III

≥40.00

≥40.00

Source: World Health Organization. BMI classification 2006 [Accessed May 31, 2011];
Available from: http://apps.who.int/bmi/index.jsp?introPage=intro_3.html
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values for most adults correlate with their amount of body fat. However, BMI does not
directly measure body fat thus may not correspond to the same degree of fatness in
different individuals and populations due to different body proportions [293]. Body mass
index values for adults are usually age-independent and apply to both men and women.
On the other hand, in children and teens BMI ranges are defined such that they take
into account normal differences in body fat between boys and girls and differences in
body fat at various ages [294]. Age and gender growth charts are used to determine the
BMI percentile in which the child or teen falls. A BMI percentile of greater than or equal
to 85, but less than 95 is categorized as overweight, and a BMI percentile of greater
than or equal to 95 is considered obese [295, 296].
Other methods such as waist circumference measurement have been
recommended for use as predictors of obesity. The National Heart, Lung, and Blood
Institute/North American Association for the Study of Obesity committee recommends
using waist circumference cut points of 40 inches (102 cm) for men and 35 inches (88
cm) for women as a measure of „central obesity‟ [297]. Research shows that waist
circumference is a better predictor of obesity-related diseases than overall obesity
assessed by using BMI [298, 299]. Moreover, it‟s high predictive value for future health
risks, ease of measurement, and understanding by the general public make waist
circumference measurement an equally or more useful tool than BMI [297-299].
Excess abdominal fat is an important, independent risk factor for disease. A
disproportionate amount of body fat that is especially distributed around the waist,
creates a greater risk of developing high blood pressure, high blood cholesterol,
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diabetes, heart disease, and stroke [25]. Independently, obesity seriously increases the
risk of developing CVD. Obesity is associated with high levels of LDL and triglyceride
levels, lower levels of HDL, higher blood pressure, and diabetes [25, 300]. A high BMI
(BMI≥25) is associated with an increased risk of stroke in men [301, 302] and women
[303, 304]. In addition, there is a dose-response relationship between ischemic stroke
risk and BMI [301, 303, 305]. Abdominal adiposity (measured by waist-to-hip ratio) has
been found to be associated with increased stroke rate than overall body mass
(measured by BMI) [303, 306, 307]. Although no clinical trial has tested the effects of
weight reduction on stroke outcomes, weight reduction is associated with a lowering in
blood pressure [308] and may therefore contribute to a reduced stroke risk.
Obesity and overweight are strongly related to early age occurrence of first MI in
individuals [309, 310]. However, several studies have reported an apparent paradoxical
effect of BMI on outcomes. Body mass index seems to be associated with better
survival as obese and overweight patients showed better survival compared to those
with normal BMI [311, 312]. In patients with acute MI, high BMI appears to have an
unexplained protective effect on survival [313-315]. This obesity paradox continues to
invoke debate about the importance of increased BMI as an independent risk factor for
coronary heart disease.
Although overweight and obesity were once considered a problem only in highincome countries, these conditions are now dramatically on the rise in low- and middleincome countries, particularly in urban settings. The WHO projections suggest that the
number of overweight people globally will increase to 2.3 billion and more than 700
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million will be obese by 2015 [169]. In 2008, the prevalence of overweight in England
among men was 42% while that among women was 32%. An additional 25% of men
and 28% of women in England were obese [258]. About 14.1 million Canadians are
overweight or obese, and of these, about 5.5 million are obese [170].
Obesity in the US has reached epidemic proportions. Between 1980 and 2002,
obesity prevalence doubled in adults (≥20 years) and overweight prevalence tripled in
children and adolescents aged 6-19 years [316-318]. In 2008, about 68% of US adults
(≥20 years) were either overweight or obese. Of these, about 34% were obese. The
prevalence of overweight and obesity among children 2-19 years of age was 31.9% and
16.3%, respectively [21]. Additionally, the prevalence of obesity among men rose from
28% between 1999 and 2000 to 32% between 2007 and 2008, whereas the prevalence
among women rose from 33% to 36% in the same period. According to the
CDC/BRFSS 2008 data, the prevalence of obesity ranged from 19.1% in Colorado to
33.3% in Mississippi [319]. Among adults, women have higher obesity risks than men
and non-Hispanic Black and Mexican American women have higher risks than nonHispanic White [317]. Approximately 68% of adults (≥18 years) in Tennessee were
overweight or obese in 2008. The prevalence of overweight adults in Tennessee did not
change significantly between 1999 and 2008. However, the percentage of obese adults
increased from 20.5% to 31.2% during this period [173].
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1.1.13.1.6 Sedentary Lifestyle
Lack of exercise or a sedentary lifestyle is a risk factor for CHD. The risk of a
fatal heart attack is nearly doubled in sedentary people than active people [292].
Results of a meta- analysis study showed that highly physically active individuals had a
lower risk of stroke and lower stroke mortality than those with low activity, who in turn
had a lower risk of stroke than those who are inactive [320]. Maintaining a healthful
activity level gives the heart capacity to pump blood efficiently and reduces the risk of
dying from heart disease. Exercise also helps to reduce other stroke and CAD risk
factors such as lowering total cholesterol and triglyceride levels and increases
protective HDL cholesterol levels, it lowers the blood sugar thus protects from
development of type 2 diabetes, it reduces the risk of developing high blood pressure as
well as promoting weight loss [25, 292]. In addition, patients with established CAD can
lower their risk of cardiac death through regular physical exercise. All individuals
regardless of body weight are advised to live a physically active life as a way of
reducing the risk of CVDs [292]. The AHA recommends at least 30 minutes of physical
activity most days of the week for adults [321].
Physical inactivity accounts for 20% of CHD and 10% of stroke burden in
developed countries [181]. Only 42% of men and 31% of women in England met the
government‟s physical activity guidelines in 2008 [258]. In Canada, nearly half of the
adults (≥12 years) are physically inactive and only 43% of people over the age of 65 are
active [170]. Most of the population of the United States is sedentary. More than 60% of
American adults and about 50% of adolescents do not get the recommended amount of
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physical activity [321, 322]. Physical inactivity is most common among women, black
and Hispanic adults, older individuals, and less affluent people [322]. According to the
National Health and Nutrition Examination Survey (NHANES) data, between 1988-1994
and 2001-2006, the proportion of adults who engaged in >12 bouts of physical activity
per month declined from 57% to 43% among men and from 49% to 43% among women
[21]. In Tennessee, the prevalence of physical inactivity in 2009 was reported to be 31%
[323].
1.1.13.1.7 Alcohol Consumption
The relationship between alcohol intake and cardiovascular health is complex,
involving both protective and harmful effects, depending on the amount and pattern of
consumption. Excessive alcohol intake increases the risk of high blood pressure, raises
the level of harmful triglycerides, adds empty calories that contribute to overweight or
obesity and thus increases the risk of CHD and stroke [324]. Research also shows an
association between frequent heavy drinking, especially over a lifetime, with
development of insulin resistance syndrome, a dangerous combination of risk factors for
heart disease [25]. Despite the fact that the risk of CHD increases with heavy drinking
[325], a substantial body of literature also indicates that CHD risk is lower among
moderate drinkers compared to non-drinkers [326, 327]. In one study, moderate
drinkers were found to have a better prognosis following a complicated MI than heavy
drinkers and non-drinkers [328]. Studies have shown that moderate alcohol
consumption (not more than one drink for women, and two drinks for men a day) raises
HDL cholesterol level, helps prevent blood clots thus reducing the risk of heart attack
and ischemic stroke [25].
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A meta-analysis of 35 observational studies found an increased risk of ischemic
stroke in people that consume more than 60g of ethanol/day (approximately six drinks)
[329]. In the same study, light to moderate alcohol consumption was associated with a
reduction in ischemic stroke risk. The apparently positive effect of light to moderate
alcohol consumption is associated with beneficial effects on lipids and hemostatic
factors [330]. The flavonoids of red wine are said to be involved in preventing the
formation of atherosclerotic plaques [331]. On the other hand, heavy alcohol intake and
binge drinking increase blood pressure and the risk of hypertension, thereby increasing
the risk of stroke [332, 333] and CHD. Heavy long term alcohol consumption (>36g/day
or more than three drinks/day) and episodic heavy drinking increase the risk of atrial
fibrillation, a major risk factor of stroke [334].
About 2% of CHD and about 5% of stroke burden in men in developed countries
is attributed to excessive alcohol consumption [181]. Thirty seven percent of men and
29% of women in Great Britain were reported to have exceeded the recommended
amount of alcohol consumption in 2008 [258]. Excessive alcohol use is the third leading
preventable cause of death in the US [335] and was responsible for approximately
79,000 deaths and 2.3 million years of potential life lost in the US each year during
2001-2005 [336]. Binge drinking, defined as consuming ≥4 alcoholic drinks on one or
more occasions for women and ≥5 drinks on one or more occasions for men, was
responsible for more than half of these deaths [337]. Of the 52% US adults (≥18 years)
reported to be regular drinkers in 2009 [338], 15.2% indulged in binge drinking [339].
The prevalence of binge drinking among men (20.8%) was twice as high as that among
women (10.0%) [339]. Geographically, 49% of adults living in the South were current
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regular drinkers, in contrast to 52% in the West, 55% in the Midwest, and 56% in the
Northeast [338]. In Tennessee, 10.5% of the adults (≥18 years) reported binge drinking
in 2008 and 3.5% reported heavy drinking (defined as men having more than 2 drinks
per day and women having more than 1 drink per day) [173].
1.1.13.1.8 Socioeconomic Factors
Indicators of socioeconomic status (SES), such as, education, income, and
occupation have been associated with coronary heart disease morbidity and mortality
[340-343]. These SES indicators are likely independent risk factors for heart disease
[344-351]. Studies have reported inverse associations between education [352, 353],
income [353], and occupation [354] with incident fatal and non-fatal MI events as well as
higher MI risks among middle-aged persons living in socially deprived neighborhoods
[347, 355]. Kelly and Weitzen found that people with less than a high school education
were more likely to have MI as compared to college graduates [352]. In the same study,
prevalence of MI decreased with increase in the life time level of education. In another
study, individuals residing in neighborhoods with low median incomes had signiﬁcantly
higher risk of MI compared to those living in neighborhoods with high median income
[356]. There is also evidence of inverse associations between stroke mortality risks
[357-359] and incidence rates [360-363] with socioeconomic status of individuals. The
mechanisms by which socioeconomic status influences stroke and MI risk are not
entirely understood. Potential explanations include differences in major stroke risk
factors [342, 364], and in access to and use of medical care [365, 366]. Inverse
relationships between SES and blood pressure, smoking, diabetes, physical inactivity,
and obesity (particularly for women) have been widely reported [367-369].
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Socioeconomic deprivation in early life has been associated with increased risk
of stroke [370-374] and CHD [374-378] in adulthood. The life course concept considers
the social and physical hazards, and the resulting behavioral, biological and
psychosocial processes, that act across all stages of the life span (gestation, infancy,
childhood, adolescence, young adulthood and midlife) to affect risk of disease later in
life [379]. Disadvantageous in-utero conditions have been shown to biologically imprint
or program disease and illness susceptibility during fetal development [380] leading to
permanent alteration of cardiovascular, endocrine, and metabolic systems thus
increasing the risk for obesity, hypertension, diabetes, and CHD in adulthood [381].
Childhood deprivation may restrict opportunities for social mobility (e.g., educational
attainment) and access to the goods and services necessary to promote and maintain
good health [382, 383]. Other findings indicate that children from disadvantaged families
learn poorer health behaviors than their better-off counterparts and are more likely to
smoke, have a poor diet, and low physical activity levels in adulthood [383] which may
increase the risk of MI and stroke. These findings imply that childhood deprivation may
act with other social and behavioral events across the life course and that social mobility
and healthy behaviors may effectively mediate the adverse relationship between
childhood deprivation and CHD [381, 382].
1.1.13.2 Non-Modifiable Risk Factors
1.1.13.2.1 Age
The prevalence of CVD, predominantly ischemic heart disease and stroke,
increases exponentially with age, and CVD remains an important cause of morbidity
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and mortality up to the oldest age categories [384]. Age tends to weaken the heart‟s
function. The heart is less able to pump blood, the heart walls may thicken, and the
artery walls may stiffen and become narrow. The increase in hypertension with age may
compound the problem, thus predisposing to MI and stroke [25]. About 82% of people
who die of CHD are 65 years or older [385]. Men over age 45 and women over age 55
are at increased risk of CAD [292]. The prevalence of MI is known to be higher in the
older population and is associated with high long-term morbidity and mortality [386,
387]. Age is probably the most important determinant of stroke as the risk of stroke
doubles for each successive decade after age 55 years [388, 389].
1.1.13.2.2 Sex
Stroke occurs in both men and women but is more prevalent in men than women
[388] especially men within the age range of 45-84 years [390]. Myocardial infarction is
also more prevalent in men than women [391]. The differences in stroke and MI risks
for both men and women may reflect differential exposure to stroke [392] and MI [393]
risk factors or differences in the relative magnitude of these risk factors for men and
women. Although women develop CAD about 10 years later in life than men [292, 393],
they have a higher mortality after MI than men mainly due to the older average age at
which women develop MI [394]. Additionally, men are more likely to suffer from MI at a
younger age while women are generally protected from heart disease by their sex
hormones until menopause [25, 292]. However, after menopause, a woman‟s risk of
heart disease starts to rise and after age 65 the risk of having CAD is about the same
as for men, and after age 75, a woman is at greater risk than a man [25]. Even though
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sex hormones seem to render some sort of protection against heart disease in women,
there is still controversy surrounding the effect of hormone replacement

therapy

(estrogen and/or progestin) in reduction of the risk of heart disease in post menopausal
women [292]. Some observational studies [395, 396] have shown beneficial effects of
hormone replacement therapy on clinical endpoints for CHD whereas

contrasting

evidence of no beneficial effect has come from some randomized clinical trials [397399].
1.1.13.2.3 Race/Ethnicity
The association between race/ethnicity, and stroke and CHD risks may be
difficult to interpret. Globally, stroke mortality does not follow any ethnic patterns [400].
However, the incidence of MI in the UK is higher in South Asians than in non-South
Asians for both sexes; and the incidence of stroke is higher in blacks than in whites for
both sexes [401]. Clear ethnic group differences exist in Canada with First Nations
people (Aboriginals) and those of African or South Asian descent having a greater risk
of heart disease and stroke than the general population [402]. In the US, clear ethnic
group differences also exist with blacks [390, 403] and some Hispanic Americans [404,
405] having higher stroke incidence and mortality risks compared to whites. Blacks also
have a higher risk of heart disease [385]. Higher prevalence of hypertension, obesity,
and diabetes within the black population are possible reasons for the higher incidence
and mortality risk of stroke [406, 407] and heart disease [385]. Incidence data from the
Northern Manhattan Stroke Study demonstrated race/ethnic differences in stroke
incidence with blacks having a 2.4-fold higher annual stroke incidence, and Caribbean
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Hispanics having a 2-fold higher annual stroke incidence compared to whites living in
the same community [390].
1.1.13.2.4 Genetic Factors
Both paternal and maternal history of stroke and MI are associated with an
increased risk of stroke [408-410] and CAD [25, 292]. Parental CHD occurring at less
than 60 years of age has been accepted as a marker of increased CHD risk in the
offspring [411]. An individual‟s risk of CAD is considered to be above average if their
father/brother developed CAD before age 55 or if their mother/sister developed it before
age 65 [292].

In a recent Framingham study, results showed that offsprings with

documented parental history of any stroke type by 65 years of age had a 2-3 fold higher
risk of stroke [412]. Moreover, offspring with positive paternal history of stroke were 4
times more likely to develop a stroke by 65 years of age.
In the past, studies indicated that increased stroke risk was not necessarily due
to “stroke genes” but may have been mediated through one or more mechanisms,
including: (1) genetic heritability of stroke risk factors, (2) genetic susceptibility to these
risk factors, (3) familial sharing of cultural/environmental and lifestyle factors associated
with stroke, and (4) the interaction between genetic and environmental factors [413].
However, recent genome-wide association analyses have suggested that several
putative genes may be responsible for this genetic risk [414, 415]. Some risk factors
that can be inherited from parents include tendency toward moderately high cholesterol
levels, high blood pressure, obesity or diabetes [292]. Genetic variation at the
chromosome 9p21.3 region has consistently been associated with increased risk of
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CHD and MI [416-419]. However, the potential mechanism by which variants in this
chromosome 9 region increase risk of CHD is still unclear [418, 419].
1.1.14 Vital Statistics
Vital statistics are those related to births (natality), deaths (mortality), marriages,
health, and disease (morbidity). In the US, vital statistics are obtained from the official
records of live births, deaths, fetal deaths, marriages, divorces, and annulments [420].
The official recording of these events resides individually with the states and
independent registration areas (District of Columbia, New York City, and territories) in
which the event occurs [420]. The vital statistics for the entire US are then published by
the National Center for Health Statistics and can be obtained from the CDC, state health
departments, county health departments and other agencies.
Mortality data provide important source of demographic, geographic, cause-ofdeath information, and are valuable for surveillance of cause-specific mortality. In this
study, MI and stroke mortality data obtained from Tennessee vital statistics are used to
determine the mortality risks of neighborhoods in Middle Tennessee as well as identify
high risk neighborhoods. Additionally, vital statistics provide one of the few sources of
health-related data that can be analyzed at the small geographic area level and are
available for long periods thus important in assessment of temporal trends in cause
specific mortality. This is evident in this study as temporal trends of MI and stroke
mortality risks across the study period were computed. These data can also be used to
present the characteristics of individuals dying of specific diseases (which is important
in determining potential predictors of disease), to determine life expectancy, and to
compare mortality trends with other countries [421]. Mortality data are also widely used
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as indicators of health status or for healthcare needs evaluation [156]. High mortality
risks are indicative of a high burden of disease. Thus, mortality data can be used to
identify geographical areas in which healthcare resources are most needed. Therefore,
vital statistics records provide a rich source of data to epidemiologists and other health
and medical investigators for health research.
1.1.15 Summary
Disparities in access to healthcare services and the resulting adverse health
outcomes are major public health priorities. Distance to healthcare is one of the most
important geographic factors that may affect access to care and therefore health
outcomes [156]. Although there is an overwhelming amount of research about MI and
stroke disparities in healthcare access and health outcomes, research linking mortality
risks of specific regions of the country to access to healthcare services is important in
providing information to guide health programs intended to reduce these disparities.
Currently, most population health planning interventions are based on disease
spatial patterns observed at the county level or higher geographic units. However, the
use of such a large unit of analysis limits the ability to identify specific disease spatial
patterns at the lower levels, such as neighborhoods. In the current study,
neighborhoods lacking timely access to MI and stroke care were identified.
Furthermore, MI and stroke mortality data of neighborhoods in Middle Tennessee were
used to investigate and identify MI and stroke high risk clusters. Research relating
mortality data to the geographical location of healthcare services is vital in helping
healthcare planners and policy makers achieve equitable distribution of resources.
Additionally, assessment of temporal trends in mortality risks and disparities in access
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to healthcare is important in evaluation of intervention strategies and in implementation
of needs-based population health planning and service provision. This is important for
reducing the burden of MI and stroke in high risk populations thus improving the health
of the entire population.
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2.1 Abstract
The objective of this study was to investigate temporal changes in geographic access to
emergency heart attack and stroke care. Network Analysis was used to compute travel
time to the nearest emergency department (ED), cardiac, and stroke centers in Middle
Tennessee. Populations within 30, 60, and 90 minutes driving time to the nearest ED,
cardiac and stroke centers were identified. There were improvements in timely access
to cardiac and stroke centers over the study period (1999-2010). There were significant
increases in the proportion of the population with access to cardiac centers within 30
minutes from 29.4% (1999) to 62.4% (2009) while that for stroke changed from 5.4%
(2004) to 46.1% (2010). Most (96%) of the population had access to an ED within 30
minutes. Access to care has improved in the last decade but more still needs to be done
to address disparities in rural communities.

2.2 Introduction
Coronary heart disease, including heart attack, is the leading cause of death in
the United States while stroke is the leading cause of adult disability and third leading
cause of death [12]. Out of 700,000 individuals that have stroke in the United States
each year, 167,000 die [422] and about 15-30% of the survivors are severely disabled
[12]. Heart attack, also known as myocardial infarction (MI) and stroke are of great
economic burden to the US health system. The estimated combined direct and indirect
costs of MI and stroke in 2010 was an astounding 250.8 billion dollars [12].
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Myocardial infarction occurs as a result of blockage of blood flow to the heart
muscle mainly due to formation of a blood clot in the coronary artery. Treatments for MI
include, but are not limited to, pain control, use of thrombolytics, surgical procedures
including coronary artery bypass, and heart transplantations. Other procedures such as
percutaneous coronary interventions (PCI), which involve cardiac catheterization, are
increasingly being used [423]. For these treatments to be successful, it is critical that
they are given as soon as possible after onset of symptoms. The current American and
European guidelines suggest cardiac catheterization be done within 90 minutes of first
medical contact [424, 425]. Moreover, it is recommended that these procedures be
done in hospitals equipped with a catheterization laboratory and specialized team that
must be available 24 hours a day [75]. Therefore, not every hospital can appropriately
perform these procedures, and so some patients have to travel long distances to get
access to a hospital with these facilities and personnel. Long distances and travel times
may therefore have a significant impact on patient survival. For instance, out of 1.2
million people who suffer an acute MI each year in the United States, more than 50%
die before reaching a hospital or in an emergency department [422]. It has been
reported that prolonged transport time to an appropriate cardiac center is one of the
factors that contributes to these deaths [426]. Moreover, studies have shown that MI
patients who live in close proximity to cardiac centers are more likely to receive invasive
cardiac procedures such as cardiac catheterizations compared to those that are further
away from the cardiac centers [161, 427]. Unfortunately, only about 25% of the
hospitals in the United States are capable of performing cardiac catheterization [428].
This limitation places a barrier in receiving this intervention for some MI patients, and
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therefore highlights the need for quick transportation of patients to the few available
cardiac centers.
Stroke is an acute neurological injury that results from interrupted blood supply to
part of the brain. The primary treatment for acute ischemic stroke is early administration
of thrombolytics. However, due to the risks involved in thrombolytic therapy, it is
recommended that it is administered only by physicians trained in its use and in centers
with the necessary resources to handle complications [115]. Better health outcomes
have been observed in patients when thrombolytic treatment is administered
intravenously within 3 hours of symptom onset [429]. Even within the 3-hour
recommended treatment window, the odds of improvement decrease as time from
symptom onset to treatment increases [430]. It is reported that half of stroke deaths
occur before the patients reach the hospital [10, 431]. Therefore, early transport to
appropriate hospitals and early treatment of these patients would prevent or reduce the
number of deaths, disabilities or complications [432]. This emphasizes the need for
quick transportation of patients to appropriate stroke centers.
The recommended 90- and 180-minute treatment windows for MI and stroke,
respectively, place geographic limits on the distance a patient can be located from a
cardiac or stroke center. This indicates that travel time considerations are of paramount
importance in accessing stroke and cardiac care. Identification of disparities in
geographic access to emergency cardiac and stroke care is the first step towards
reduction and elimination of these disparities and improving the health of the population.
Most past studies of geographic access to health services have used straight line
or Euclidean distance [433, 434]. More recent studies have used road network based
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travel time to assess geographic disparities in access to care [22, 435]. Travel time
estimated from road networks has increasingly become a popular method because it
accounts for travel impedances such as speed limits and therefore provides a more
realistic and accurate measure of geographic accessibility [22]. It is also considered a
better measure of geographic accessibility because of several reasons: (i) people relate
more easily to travel time than to geographic distance when making decisions on
seeking care, (ii) speed of access to care in an emergency is often assessed in time, (iii)
travelling time is a more sensitive measure than distance as it considers transportation
mode (air, ground or water transport) [436].
The American Heart Association/American Stroke Association‟s Get With the
Guidelines (GWTG) program for coronary artery disease (CAD) and stroke established
in 2001 and 2004, respectively, was to ensure consistent application of the latest
evidence–based scientific guidelines in the treatment of stroke and CAD, including heart
attack [437]. With more hospitals adopting the GWTG programs and achieving
accreditation status, there is bound to be changes in disparities of timely access to
emergency care over time. Therefore, in this study we used network analysis to
investigate temporal changes in geographic disparities of timely access to emergency
stroke and heart attack care. To the best of our knowledge, this is the first study to use
network analysis to investigate temporal changes in geographic disparities of access to
health care in the US. Identification of geographic disparities in access to care services
is useful for guiding equitable resource allocation and policy decisions geared towards
achieving one of the Healthy People 2020 objectives of elimination of health access
disparities [438] thus improving the health of the entire population.
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2.3 Methods
2.3.1 Study Area
Middle Tennessee is used as a case study in this research although the
methodology is applicable to any other geographical region. Thus the current study was
carried out in 30 counties of Middle Tennessee (Figure 2.1) using data for 1999-2010.
Most of the counties in this area lie in the “stroke belt” of Tennessee, a region with high
stroke and MI prevalence. The area consists of 250 census tracts and spans about
12,045 square miles with a total population of approximately 1.2 million people. It was
important to include a 4-8 county “buffer” around the study area to allow for the fact that
some residents may seek care in neighboring counties (outside the study area) (Figure
2.1). The geographic size of the neighboring counties influenced the number of buffer
counties included in the analysis. Thus, in areas where most of the counties were of
small geographic size, more counties were included, whereas in areas where the
neighboring counties were relatively geographically large, fewer counties were included
in the “buffer.”
2.3.2 Data Sources and Preparation
2.3.2.1 Hospital Data
Geographic location data of accredited cardiac and stroke centers as well as
other hospitals with an emergency department (ED) were obtained from the Joint
Commission on Accreditation of Health Organizations (JCAHO) Web site [439]. The
JCAHO is a body responsible for accreditation of care centers that meet specific criteria
for providing specialized medical services. Cardiac centers were defined as hospitals
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Figure 2.1: Map of Study Area and Neighboring (Buffer) Counties
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capable of providing percutaneous coronary intervention services whereas stroke
centers were defined as those that comply with the Brain Attack Coalition guidelines
[440]. The EDs were defined as hospitals capable of providing emergency care. The
street addresses of all the qualifying care centers were geocoded using batchgeo [441]
and mapped using ArcGIS Version 9.3 [442]. Hospitals were contacted to determine the
initial year of accreditation. In order to assess temporal changes in disparities of access
to timely emergency stroke and heart attack care, analyses were performed for each
year when there were changes in the number of care centers of interest (cardiac or
stroke) during the study period. For cardiac centers this occurred in 1999, 2007, 2009,
and 2010 while for stroke centers it was in 2004, 2005, 2006, 2007, and 2010. For ED,
two analyses were performed, in 1999 and 2010.
2.3.2.2 Street Network Data
The street network dataset was obtained from Streetmap USA [443]. These data
provided segment-by-segment information on street names, legal speed limits, distance,
road connectivity and turn impedances, which are required to perform realistic travel
time calculations. The North American Datum 1983 State Plane coordinate system with
the high accuracy reference network for Tennessee was the reference system used
because it uses Lambert conformal conic projection, which minimizes scale distortion
allowing for accurate distance computations. Travel time for each street segment was
calculated using the field geometry calculator in ArcGIS 9.3, as follows: travel time
(minutes) = length of the segment (miles)/speed limit (miles/minute).
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2.3.2.3 Cartographic Boundary Files
The cartographic boundary files for census tracts were downloaded from the US
Census Bureau [444]. These data were used for overlaying the street dataset and the
care center locations. The main geographic unit of analysis used was a census tract.
Census tracts are small, county statistical subdivisions that contain between 2,500 and
8,000 people. In this study, census tracts were used to represent neighborhoods
because they are good proxies of natural neighborhood boundaries and are
homogenous with respect to population characteristics [226].
2.3.2.4 Population Data
Census tract and block group-level population data were obtained from the 2000
Census summary file 3 [445]. In this study, population weighted centroids of census
tracts (based on block group-level population data) were used instead of simple
geographic centroids because they correspond to the approximate locations that are
closest to where most residents in the census tract live. Census tract population
characteristics (potential risk factors for MI and stroke), such as, proportion of
individuals aged ≥65 years, below poverty level, with utmost elementary education, as
well as the median household income and the median housing value were also obtained
from the 2000 Census summary file 3 [445].
2.3.2.5 Mortality Data
The MI and stroke mortality data used to calculate mortality risks for
neighborhoods within each travel time was obtained from the Tennessee Department of
Health. Only mortality data for the years 1999-2007 was available for the study. Deaths
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from stroke and MI were defined on the basis of underlying cause of death. The
International Classification of Diseases, Tenth Revision (ICD-10) codes used were I21I22 for MI and I63-I64 for stroke. Cases were geocoded based on their residential
addresses.
2.3.3 Network Analysis
This technique uses road network data to calculate distances between points or
nodes on a network. Hence, the first step was to build a network dataset of the study
area. Network datasets consist of a series of segments or links that are joined by nodes
(intersections), and each link is assigned a travel cost, which in this case was time
(measured in minutes). Nodes represent a point (care center or population centroid of a
census tract) of interest within the network whereas links are the connections (roads)
that allow flow between the nodes. Each road segment in the network has a known
length/distance and associated speed limit that allow for calculation of travel time.
Therefore, travel time (in minutes) for each road segment in the study area was
determined. Travel time from each neighborhood population centroid to the nearest
cardiac or stroke center along the road network was calculated using network analyst‟s
service area solver function. This function uses Dijkstra‟s shortest path algorithm [446]
to compute the shortest path between each population centroid and the closest cardiac
or stroke center. This algorithm works by first computing travel times along all possible
routes connecting the origin (neighborhood population centroids) and destinations
(cardiac and stroke centers) within a given travel time limit, which was 30, 60, and 90
minutes in this study. The travel time is minimized by hierarchical routing where driving
on higher-level roads (interstate highways) is preferable to driving on lower-level roads
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(local roads) [447]. Thus, the service area solver function generated travel time zones
within the specified travel time limits: 30, 60, and 90 minutes in this study. A travel time
zone represents the area that can be reached by road within specified time limits. For
example, the 30-minute travel time zone for a hospital includes all the areas that can
reach the hospital within 30-minutes travel time [446]. Separate analyses of the 30-, 60-,
and 90-minute travel time zones for stroke, cardiac and emergency departments were
performed. In order to assess temporal changes in access, analyses were performed for
each of the years during which there were changes in the number of accredited care
centers. For cardiac centers, these occurred in 1999, 2007, 2009, and 2010 while for
stroke centers it was 2004, 2005, 2006, 2007, and 2010. Analyses of access to stroke
centers began in 2004 because accreditation of stroke centers began in 2003 [448]. For
ED, analyses were performed for 1999 and 2010 because only 1 ED was added to the
study area and 1 to the buffer counties between 1999 and 2010. Neighborhoods
(census tracts) whose population-weighted centroids were within a specified travel time
zone boundary were allocated to that travel time zone. The percentage of the population
that had access to ED, stroke, and cardiac centers within 30, 60, and 90 minutes travel
time at each of the time periods was estimated. Population characteristics of the
populations within the different cardiac and stroke travel time zones at each of the study
periods were also computed.
2.3.4 Statistical Analysis of Mortality Risks and Temporal Changes in Access
Age- and sex-adjusted mortality risks for neighborhoods in each of the travel time
periods for the years 1999-2007 (for MI) and 2004-2007 (for stroke) were computed.
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The Tennessee 2000 census population was used as the standard population for direct
standardization of the mortality risks.
To assess temporal changes in timely access, the percentage of the population
with timely access to ED, cardiac and stroke centers were computed for each time
period when changes occurred. Two-way comparisons between proportions of adjacent
time periods were then performed using two-sample test of proportions in Stata version
11.0 (Stata Corp., College Station, TX). Simes method was used to adjust for multiple
comparisons. To assess temporal trends, tests for trend in the proportions of
populations and mortality risks for both MI and stroke were performed.

2.4 Results
2.4.1 Distribution of Care Centers
The number of accredited cardiac and stroke centers in the study area increased
over time (Tables 2.1 and 2.2). The number of cardiac centers in the study area
increased from 2 in 1999 to 7 in 2010 (Table 2.1; Figures 2.2 and 2.3). The lowest (7)
number of cardiac centers in the buffer counties was observed in 1999 while the highest
(35) was in 2010 (Table 2.1). Of the 7 cardiac centers in the study area in 2010, 3 were
located in Hamilton county, 2 in Rutherford, and one in each of Coffee and Putnam
counties (Figure 2.3b). It is worth noting that all the stroke centers were also cardiac
centers. The distribution of stroke centers followed a similar temporal trend with the
lowest number of stroke centers in both the study area and buffer region recorded in
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Table 2.1: Changes in the Number of Cardiac Centers, Neighborhoods and Populations with Access to
Emergency Cardiac Care at Different Times in Middle Tennessee, 1999-2010

Year

Number of Cardiac Centers
Study Area

Travel Time (min)

Buffer Counties

1999

2

7

2007

3

12

2009

6

26

2010

7

35

0 - 30
>30 - 60
>60 - 90
>90
0 - 30
>30 - 60
>60 - 90
>90
0 - 30
>30 - 60
>60 - 90
>90
0 - 30
>30 - 60
>60 - 90
>90
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Number of

Number of

Neighborhoods

People

60
50
103
37
128
58
49
15
147
86
17
0
148
88
14
0

352,807
222,542
433,213
189,419
657,753
275,581
208,878
55,769
748,018
387,276
62,687
0
751,391
396,085
50,505
0

% Pop

29.4
18.6
36.2
15.8
54.9
23.0
17.4
4.7
62.4
32.3
5.2
0
62.7
33.1
4.2
0

Table 2.2: Changes in the Number of Stroke Centers, Neighborhoods and Populations with Access to Emergency
Stroke Care at Different Times in Middle Tennessee, 1999-2010

Year

Stroke Center Number
Study Area

Travel Time (min)

Neighborhoods

Buffer Counties

2004

0

1

2005

0

5

2006

0

11

2007

1

15

2010

2

21

Number of

% Pop

People
0 - 30
>30 - 60
>60 - 90
>90
0 - 30
>30 - 60
>60 - 90
>90
0 - 30
>30 - 60
>60 - 90
>90
0 - 30
>30 - 60
>60 - 90
>90
0 - 30
>30 - 60
>60 - 90
>90
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9
41
62
138
12
44
60
134
44
84
81
41
67
94
71
18
107
70
56
17

63,679
233,931
277,891
622,480
79,095
239,580
281,927
597,379
195,195
451,042
403,427
148,317
341,999
458,760
332,708
64,514
551,956
328,824
256,783
60,418

5.4
19.5
23.2
51.9
6.6
20.0
23.5
49.9
16.3
37.7
33.7
12.3
28.5
38.3
27.8
5.4
46.1
27.4
21.4
5.1

Figure 2.2: Travel Time to Cardiac Centers in Middle Tennessee in (a) 1999 and (b)
2007
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Figure 2.3: Travel Time to Cardiac Centers in Middle Tennessee in (a) 2009 and (b)
2010
86

2004 and the highest in 2010 (Table 2.2). Notably, there were no accredited stroke
centers in the study area until 2007 (Table 2.2 and Figures 2.4 and 2.5). However, a
number of stroke centers were located in the buffer counties from 2004 through 2010
(Table 2.2 and Figures 2.4, 2.5, and 2.6). As expected, most of the cardiac and stroke
centers were located in the major cities. For instance, the only 2 stroke centers in the
study area in 2010 were located in the two major cities; Murfreesboro (Rutherford
County) and Chattanooga (Hamilton County) (Figure 2.6). The number of EDs in both
the study area and the buffer counties did not change significantly between 1999 and
2010. Only two EDs were added during the study period; one in the study area in 2003
and the other in the buffer county in 2002. There were 35 hospitals with EDs in the
study area and 69 in the buffer counties in 2010 (Figure 2.7). The spatial distribution of
EDs followed a similar trend as for the cardiac and stroke centers with 7 of the 8 EDs in
Hamilton County located in Chattanooga and 2 of the 3 EDs in Rutherford County
located in Murfreesboro. Unfortunately, some counties, such as Grundy, Jackson,
Moore, Sequatchie, Pickett, and Van Buren did not have any hospitals with an
emergency department for the entire study period (Figure 2.7).
2.4.2 Disparities in Geographic Access
Generally, the population with timely access to emergency care for the two
conditions increased over time. There were significant (p<0.0001) increases in the
percentages of the population that had access to cardiac and stroke centers at different
travel time intervals (30, 60, and 90 minutes) over the study period. Most evident was a
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Figure 2.4: Travel Time to Stroke Centers in Middle Tennessee in (a) 2004 and (b)
2005
88

Figure 2.5: Travel Time to Stroke Centers in Middle Tennessee in (a) 2006 and (b)
2007
89

Figure 2.6: Travel Time to Stroke Centers in Middle Tennessee, 2010
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Figure 2.7: Travel Time to Hospitals with an Emergency Department in Middle Tennessee, 2010
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temporal increase in the number of neighborhoods and the percentage of the population
that had timely geographic access to cardiac (Table 2.1) and stroke (Table 2.2) centers
over the study period. The number of neighborhoods with access to a cardiac center
within 90 minutes rose from 213 in 1999 to 235 in 2007 (Table 2.1). With the exception
of a few neighborhoods in Fentress County, most neighborhoods in the study area had
access to a cardiac center within 90 minutes in both 2009 and 2010.
The percentage of the population that had access to a cardiac center within 30
minutes rose from 29.4% in 1999 to 62.7% in 2010 (Table 2.1). A total of 37 and 15
neighborhoods representing 15.8% and 4.7% of the study population had no access to
a cardiac center within 90 minutes in 1999 and 2007, respectively (Table 2.1). Most of
these neighborhoods were consistently located in the more rural counties of Bledsoe,
Clay, Fentress, Jackson, Overton, Pickett, Sequatchie, Van Buren, and White.
Although access to stroke centers was more limited, a similar increasing
temporal trend was observed over the study period. The percentage of the population
that had access to a stroke center within 30 minutes rose from 5.4% in 2004 to 46.1% in
2010 (Table 2.2). Several neighborhoods had no access to a stroke center within 90
minutes throughout the study period (Table 2.2 and Figures 2.4, 2.5, and 2.6). However,
it is interesting to note that the percentage of the population that had no access to a
stroke center within 90 minutes declined from 51.9% in 2004 to 5.1% in 2010 (Table
2.2). The proportion of the population with access to stroke centers was similar for 2008
through 2010.
The percentage of the population with access to an ED was similar for both 1999
and 2010. Most (96%) of the study population could access a hospital with an
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emergency department within 30 minutes and the entire study area population had
access to an ED within 60 minutes. Some areas of Grundy, Sequatchie, Jackson,
Overton and Van Buren counties had no access to an ED within 30 minutes (Figure
2.7). Since the results for both 1999 and 2010 were similar, we present only the results
of 2010. Additionally, since all neighborhoods were within 60 minutes of an ER, the map
of access to an ER does not include the 90 minutes travel time zone (Figure 2.7).
2.4.3 Population Characteristics of Neighborhoods Within Travel Time Zones
The proportions of the population within 60 minutes of a cardiac center that were
65 years and older, living in rural areas, below poverty level, and had utmost elementary
education increased between 1999 and 2007 (Table 2.3). Similar changes were
observed for stroke with respect to neighborhoods that had access within 30 minutes of
a stroke center. On the other hand, there were decreasing proportions of those with
access to stroke centers over 90 minutes (Table 2.4). Interestingly, for all the study
periods considered, neighborhoods within 30 minutes of cardiac care had the highest
median household income and median housing value (Table 2.3) implying that
neighborhoods with lower income tended to be further away from cardiac centers.
Similarly, with the exception of the 2006 study period, median household income and
median housing value tended to be lower in neighborhoods that had longer travel times
to a stroke center (Table 2.4).
2.4.4 Age- and Sex-adjusted Mortality Risks Across Travel Time Zones
There was a total of 9,822 MI and 4,919 stroke deaths over the study period.
Mortality risk for MI was lower in neighborhoods that were within 30 minutes of a cardiac
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Table 2.3: Socioeconomic and Demographic Characteristics of Populations with Different Levels of Access to
Cardiac Centers in Middle Tennessee, 1999-2010

Year

1999

2007

2009

2010

Travel
Time
(Min)
0 - 30
>30 - 60
>60 - 90
>90
0 - 30
>30 - 60
>60 - 90
>90
0 - 30
>30 - 60
>60 - 90
>90
0 - 30
>30 - 60
>60 - 90
>90

Pop 65 Years
and Above

Pop in Rural
Areas

Pop Below
Poverty

Number

%

Number

%

Number

%

35,382
30,811
64,373
23,743
77,819
37,055
30,806
8,629
89,922
55,766
8,621
0
90,319
57,320
6,670
0

22.9
19.9
41.8
15.4
50.4
24.0
20.0
5.6
58.3
36.1
5.6
0
58.5
37.1
4.3
0

139,728
154,731
167,893
101,970
165,075
197,859
148,755
52,633
213,479
293,790
57,053
0
216,852
296,974
50,496
0

24.8
27.4
29.7
18.1
29.2
35.1
26.4
9.3
37.8
52.1
10.1
0
38.4
52.6
9.0
0

34,184
30,886
63,640
20,716
70,609
37,843
30,875
10,099
83,711
54,681
11,034
0
84,040
55,859
9,527
0

22.9
20.7
42.6
13.8
47.3
25.3
20.7
6.7
56.0
36.6
7.4
0
56.2
37.4
6.4
0
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Pop with Utmost
Elementary
Education
Number
%
15,640
19,421
30,691
14,626
27,236
24,150
20,239
8,753
35,168
37,251
7,959
0
35,362
37,935
7,081
0

19.5
24.2
38.2
18.1
33.9
30.0
25.2
10.9
43.8
46.3
9.9
0
44.0
47.2
8.8
0

Median
Household
Income
42,808
34,696
31,006
31,689
37,755
34,076
30,291
25,813
37,134
31,746
28,607
0
37,173
31,747
27,962
0

Median
Housing Value

97,850
80,000
74,500
73,200
88,950
78,500
73,500
60,700
87,500
74,550
61,500
0
87,400
74,550
57,150
0

Table 2.4: Socioeconomic and Demographic Characteristics of Populations with Different Levels of Access to
Stroke Centers in Middle Tennessee, 1999-2010

Year

2004

2005

2006

2007

2010

Travel
Time
(Min)

Pop 65 Years and
Above

Pop in Rural Areas

Pop Below Poverty

Pop with Utmost
Elementary Education

Median
Household
Income

Median
Housing
Value

Number

%

Number

%

Number

%

Number

%

0 - 30
>30 - 60

3,776
21,525

2.4
14.0

8,493
108,447

1.5
19.2

3,242
21,625

2.2
14.5

1,507
10,535

1.9
13.1

54,213
44,507

120,800
103,600

>60 - 90

38,747

25.1

160,641

28.5

39,884

26.7

22,626

28.1

34,652

78,700

>90

90,261

58.5

286,741

50.8

84,675

56.7

45,710

56.9

30,882

71,700

0 - 30

4,827

3.1

10,960

1.9

4,014

2.7

1,852

2.3

55,888

122,450

>30 - 60

23,583

15.3

114,905

20.4

23,641

15.8

11,991

14.9

40,133

101,250

>60 - 90

39,693

25.7

167,800

29.7

40,618

27.2

22,802

28.4

33,646

77,500

>90

86,206

55.9

270,657

48.0

81,153

54.3

43,733

54.4

31,038

72,350

0 - 30

21,904

14.2

13,389

2.4

22,232

14.9

6,834

8.5

36,447

87,750

>30 - 60

51,845

33.6

157,181

27.9

44,433

29.7

20,512

25.5

40,509

93,950

>60 - 90

58,760

38.1

261,467

46.3

59,016

39.5

34,727

43.2

31,938

76,600

>90

21,800

14.1

132,285

23.4

23,745

15.9

18,305

22.8

28,490

68,300

0 - 30

34,983

22.7

76,697

13.6

36,336

24.3

12,380

15.4

39,470

92,900

>30 - 60

60,821

39.4

190,763

33.8

51,543

34.5

26,189

32.6

36,825

83,950

>60 - 90

48,803

31.6

235,432

41.7

50,108

33.5

31,801

39.6

30,865

74,500

>90

9,702

6.3

61,430

10.9

11,439

7.7

10,008

12.5

25,941

60,350

0 - 30

62,327

40.4

112,748

19.9

56,245

37.6

19,888

24.7

39,871

92,900

>30 - 60

44,215

28.7

218,105

38.6

43,360

29.0

26,265

32.7

35,019

77,950

>60 - 90

38,417

24.9

176,135

31.2

38,979

26.1

24,686

30.7

30,491

74,550

>90

9,350

6.0

57,334

10.2

10,842

7.3

9,539

11.9

25,902

60,700
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center compared to those that were within >30-60 minutes (Figure 2.8a). Generally, MI
mortality risks decreased over the study period with risks in neighborhoods that were
within 30 minutes decreasing from 88.7 in 1999 to 67.1 in 2007 while that for
neighborhoods that were within >30-60 minutes travel time decreased from 116.7 in
1999 to 89.5 in 2007 (Figure 2.8a). Although the pattern of change in the stroke
mortality risks of the neighborhoods in the travel time zones was not consistent across
the study periods, the mortality risks recorded in 2007 were lower than those recorded
in 2004 for all the travel time zones (Figure 2.8b). Other graphs showing the temporal
changes in the mortality risks for neighborhoods within different travel time zones for
both MI and stroke can be found in appendix 1 and appendix 2, respectively. The tests
for trend in the proportions of populations and mortality risks for both MI and stroke
were significant (p<0.0001) implying significant changes during the study period.

2.5 Discussion
The results of this study undoubtedly depict significant temporal changes in
geographic disparities of access to stroke and cardiac centers. Despite important
improvements observed in geographic access to stroke and cardiac centers during the
study period, disparities in geographic access still exist especially for emergency stroke
care. Not surprisingly, clear differences were apparent between urban and rural areas,
with drive times to care centers being generally longer in rural neighborhoods because
most of the care centers were located in urban areas. This is in agreement with several
other studies [22, 449-452] that have documented inequitable distribution of health
services between rural and urban populations. Pedigo and Odoi [22] investigated
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Figure 2.8: Temporal Changes in the Mortality Risks of Neighborhoods with
Access to a (a) Cardiac Center and (b) Stroke Center within 30 and 60 Minutes
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disparities in access to heart attack and stroke care in East Tennessee and found that
most of the neighborhoods with poor access were those in the rural mountaneous parts
of the study area. Their study did not investigate changes in disparities of access
overtime; however, they found that 8% and 15% of the study population did not have
timely access to emergency stroke and MI care by road ambulance, respectively. They
also observed that travel by air ambulances greatly improved access to both MI and
stroke resulting in all neighborhoods (both urban and rural) having access to
appropriate care within 30 minutes. They argued that although it may not be practical or
cost effective to add additional stroke or cardiac centers, in order to improve access for
rural communities, use of air ambulances may be quite beneficial for these
neighborhoods. Similar to our study, they found that 96% of their study area population
had access to an ED within 30 minutes. These together with the use of telemedicine,
could play a key role in stabilizing the patients before or during transportation to
appropriate cardiac and stroke centers. This finding is important for public health
planning and resource allocation.
Significant improvements in access to care centers were observed as the
number of JCAHO accredited centers increased significantly during the study period. It
is important to note that whereas in 1999 most of the potential high risk populations
(those aged ≥65 years, below poverty level, and those with utmost elementary
education) were not within 60 minutes of a cardiac center and 90 minutes of a stroke
center, in 2010 most of them had access to cardiac and stroke care within 60 and 90
minutes, respectively. This is indicative of the progress that has been made to improve
access to emergency health services over time. This improvement can in part be
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attributed to the AHA/ASA and other organizations that have made efforts to improve
stroke and heart attack treatments and outcomes in patients. In particular, the AHA‟s
GWTG program which has been shown to not only improve patient outcomes but also
earn participating hospitals national recognition as centers of excellence in the
treatment of stroke and cardiac events [437]. This has motivated more hospitals to
implement their programs as a way of achieving recognition and excellence. Hospitals
that implement the GWTG programs are most likely to be accredited by the JCAHO
since most performance measures for the two programs are similar [141, 437]. An
increase in the number of accredited centers implies that more patients can access the
time sensitive treatments as observed in the study. For ED, the percentage of the
population with access did not change between 1999 and 2010 (even with addition of
one ED in the study area in 2003), because this ED was located in the urban area of
Murfreesboro which already had another ED center thus did not create any changes as
regards to timely accessibility since both EDs were located in the same area.
A very interesting finding of this study was that for all the study periods for both
MI and stroke (except 2006), neighborhoods furthest away from cardiac and stroke
centers had the lowest median household income and median housing value. This gives
evidence that economically disadvantaged neighborhoods are normally faced with
geographic accessibility problems compared to the affluent ones. Moreover, mortality
risks also tended to be lowest among neighborhoods closest to the care centers
compared to those that were much further away. This helps strengthen the evidence
that geographic access to care impacts health outcomes observed at the neighborhood
level and therefore should impact health planning strategies.
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The MI guidelines suggest that the estimated door-to-treatment time (that is, time
required for initial evaluation of a heart attack patient, performing the electrocardiogram,
laboratory tests, and mobilizing the catheterization team) should not exceed 30 minutes
[425, 453]. Since the maximum allowable time for cardiac catheterization is 90 minutes
[424, 425], this leaves, on average, only 60 minutes as the maximum travel time for a
patient to reach a cardiac center in order to receive therapy in the recommended time
frame. Interestingly, in 2009 and 2010, 94.7% and 95.8% of the population in the study
had access to cardiac care within 60 minutes, respectively. These percentages are
similar to that reported by Pedigo and Odoi [22], where about 98% of the population in
East Tennessee had access to cardiac care within 60 minutes. However, the observed
percentages are greater than the one reported by Nallamothu [454], in which 80% of the
entire United States population had access to cardiac care within 60 minutes.

In

contrast, the 80% reported by Nallamothu is greater than the 48% and 77.9% recorded
in the periods of 1999 and 2007, respectively. Additionally, it is not surprising that for the
entire study period, neighborhoods within the 60 minute travel time zone had higher
mortality risks compared to those that were within the 30 minute travel time zone.
Reports have revealed that utilization of care services tends to decline as the distance
traveled to care increases [157] and this may explain the observed high MI mortality
risk. Moreover, studies have shown that MI patients within close proximity of cardiac
centers are more likely to receive cardiac procedures such as PCI compared to those
that are further away from the cardiac centers [160, 161].
The recommended ideal door-to-treatment time (that is, time for emergency
department evaluation, computerized tomographic scan, required laboratory tests and
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thrombolytic initiation) for stroke patients is 60 minutes [455]. Since the maximum
allowable time for thrombolysis is 180 minutes [429], this leaves 120 minutes for travel
and symptom recognition. However, the time needed for symptom recognition may vary
depending on symptom presentation, time when the symptoms occur, reoccurrence of
stroke or knowledge of stroke symptoms by the patients or family members [456].
Based on the variable nature of the time from onset to symptom recognition, we
determined that on average, the patient would need a maximum of 90 minutes of travel
time in order to be on time for thrombolytic therapy. It is therefore worthwhile to note
that 51.9%, 49.9%, 12.3%, 5.4%, and 5.1% of the population in the study area could not
access a stroke center within 90 minutes in 2004, 2005, 2006, 2007, and 2010,
respectively. These percentages are greater than the one reported by Pedigo and Odoi
[22], where only about 1% of the population in East Tennessee did not have access to
stroke care within 90 minutes. Most of the population that had no access to a stroke
center within 90 minutes in 2010 was mainly from the rural counties of Clay, Fentress,
Jackson, Overton, and Pickett. However, the percentage of the population with access
to a stroke center within 90 minutes in 2006 (87.7%), 2007 (94.6%), and 2010 (94.9%)
was higher than that of a Canadian study reported by Scott [452], where only 78.2% of
the total Canadian population had access to stroke care within 90 minutes. In contrast,
the 78.2% reported by Scott is much higher than the 48.1% and 50.1% observed in the
current study during the years 2004 and 2005, respectively.
In this study, we use travel time calculations that are based on road networks
and actual speed limits of each road segment, which provide more realistic estimates of
travel times and therefore helps to more accurately identify neighborhoods without
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timely access to emergency care. This technique provides a much better estimate of
travel times than Euclidean distance methods that have been used by some studies in
the past [457, 458]. Euclidean distance methods have been shown to underestimate
actual travel times at lower travel speeds whereas they overestimate actual travel times
at higher travel speeds [22, 459]. This reaffirms the superiority of road network based
travel time over Euclidean distance derived travel time in measuring geographic
accessibility to healthcare. Therefore, this analytical technique provides a useful
measure of geographical access to healthcare. The results are useful for guiding health
planning decisions aimed at reduction of health disparities in neighborhoods. With the
increasing availability of network analysis tools (such as ESRI‟s network analysis
extension), health planners should be able to apply these techniques to better inform
planning decisions. Moreover, these analyses can be iteratively performed to reflect
changes in road networks (such as construction of new roads and changes in speed
limits of road segments). However, this technique is not without limitations. Firstly,
ambulances may not travel at the legal speed limits (on which we based our travel time
estimates) and are also exempted from restrictions, like traffic lights. Additionally,
changes in driving conditions such as periods of traffic congestion affect driving speeds
and therefore travel times. These factors were not adjusted for in the model because
several attempts to acquire information regarding the actual travel speeds of
ambulances (that is, how fast above the legal speed limits) were unsuccessful.
Nevertheless, considering about 50% of MI [460] and stroke [461] patients use selftransport and are therefore subjected to the standard traffic laws used in this analysis,
we believe that study findings will be quite applicable and useful to inform planning
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decisions. Data on travel impedances which may affect travel speed, such as, traffic
congestion, weather conditions, and time of day were not available thus were not
adjusted for. Secondly, due to financial constraints, the Streetmap USA version of 2007
was used for all the study periods. Although some changes may have occurred in the
road network, we believe that these changes had minimal effects on the results. Lastly,
network analysis technique is quite computer intensive and requires relatively high-end
computers when dealing with a large number of nodes and geographical units.
However, with the increased availability of more powerful computers at more affordable
prices, this will not be a problem in the future.
The above limitations notwithstanding, our results show improved geographic
access to stroke and cardiac centers over the study period although gaps in geographic
access to stroke care particularly in rural neighborhoods still exist. Hence, there is still
need for strategies to improve geographic access to emergency care for cardiac and
stroke patients. This will play a vital role in achieving the Healthy People 2020 [438]
goals of reducing disparities in access. Addressing disparities in timely access to
emergency care will require a multifaceted approach involving increased use of air
ambulance, telemedicine and education of the public on symptoms of stroke and MI.
Reducing the time from symptom occurrence to treatment will be achieved through
prompt recognition of symptoms and seeking early treatment. Early recognition of
symptoms reduces part of the pre-hospital delay and thus ensures arrival of the patients
to care centers in time to receive therapy. Instead of calling the primary physicians first,
the public should be educated to call emergency medical services (EMS) immediately
stroke or heart attack symptoms are observed. This action also reduces pre-hospital
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delays and ensures timely arrival at the hospital. In one study potential stroke patients
who first called their primary physician arrived at the emergency department within a
mean time of 379 minutes, compared with a mean time of 155 minutes for patients who
called EMS right away [460]. In the same study, only 50% of heart attack patients were
found to use EMS in a pre-hospital setting. Due to financial implications involved in
using EMS, patients and caregivers tend to self transport instead of using an
ambulance. Moreover, use of EMS has been shown to reduce pre-hospital delay and is
recognized to be the most optimum means of providing emergency care [462].
Therefore, the public should be educated on the time-sensitive nature of stroke and
heart attack treatments and the EMS‟s ability to deliver the patients to care centers
faster than self transport. This will in turn guide patients and care givers in making
decisions deemed best for improving health outcomes for stroke and cardiac patients.
Increased use of air ambulances can be critical in remote, rural or areas with
difficult terrain that make access by road ambulances challenging. This observation was
also made by Pedigo and Odoi [22]. This implies that neighborhoods in middle
Tennessee would benefit from increased use of air ambulances. Moreover, some
studies have shown that air transport can be cost effective [131, 132]. In addition,
increased use of telemedicine is a feasible solution to bridge the gap in delivery of
cardiac and stroke care in geographic settings where timely access to cardiac and
stroke centers is otherwise not possible. Telemedicine is “the use of medical information
exchanged from one site to another via electronic communications to improve patients‟
health status” [463]. Technically, it encompasses all aspects of medicine practiced at a
distance, including use of telephone, fax, and electronic mail technology, as well as the
104

use of interactive full motion video and audio, that brings together patients and
providers separated by distance. Therefore, since the majority of the population in the
study area had access to an emergency department within 30 minutes, incorporation of
telemedicine in some of the hospitals would improve access to cardiac and stroke care
without necessarily transporting patients to cardiac and stroke centers. Moreover, use of
telemedicine facilities during ambulance transport would shorten the time that would
otherwise be spent in diagnosis at the hospital since use of telemedicine between EMS
and neurologists/cardiologists would enhance diagnosis during transport and hence
minimize time spent in diagnosis on arrival at the hospital. Telemedicine also has the
ability to link rural hospitals with regional acute stroke centers of excellence, thus
enhancing standardized, streamlined care throughout a system‟s care facilities [464].

2.6 Conclusions
These data demonstrate temporal improvement in geographic access to stroke
and cardiac centers across the study period. The research further shows that currently,
a large percentage of the population in Middle Tennessee has access to cardiac and
stroke care, however, gaps still exist in accessing stroke care, especially in rural areas.
Timely access to care is essential for delivery of definitive treatments for stroke and MI
in order to reduce complications and death. The study has also demonstrated the
usefulness of network analyses in investigating temporal changes in geographic access
to healthcare as well as in identifying underserved populations. The findings are useful
for guiding health planning programs, policy decisions and health resource allocation
and are instrumental in tailoring interventions targeted at reducing/eliminating health
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disparities at the neighborhood level with the view to improving health of the entire
population.
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3.1 Abstract
Despite significant declines in coronary heart disease and stroke mortality risks
over the past years, coronary heart disease, particularly myocardial infarction (MI), and
stroke continue to be the first and third leading causes of death in the U.S. Some
population groups continue to have a disproportionate burden of MI and stroke mortality
risks. Therefore, the objective of this study was to investigate neighborhood geographic
disparities and temporal trends in MI and stroke mortality risks in Middle Tennessee and
identify predictors of observed disparities so as to guide neighborhood health planning
programs.
Descriptive, temporal, and spatial analyses were performed on MI and stroke
mortality data obtained from the Tennessee Department of Health for the period 19992007. Global Moran‟s I and Kulldorff‟s spatial scan statistic were computed at both the
county and census tract/neighborhood levels to investigate and identify geographic hot
spots of high MI and stroke mortality risks. Negative binomial model was used to
investigate predictors of the identified geographic patterns.
Decreasing temporal trends were observed in mortality risks for both MI and
stroke. Significant (p<0.05) differences in mortality risks for sex, race, age group and
educational level categories were observed. Seven and 13 significant (p<0.05) high risk
clusters of MI mortality were identified at the county and neighborhood levels,
respectively. For stroke, 2 significant (p<0.05) high mortality risk clusters were identified
at the county level whereas 6 were identified at the neighborhood level. Neighborhoods
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with higher proportions of the older population and those with higher proportions of
individuals with low education were associated with high MI and stroke mortality risks.
Although a decreasing temporal trend was observed, substantial disparities in MI
and stroke mortality risk still exist. Identification of high risk neighborhoods is essential
for targeting resources and will aid the development of more needs-based prevention
programs. This is crucial in addressing one of the goals of the Healthy People 2020 of
reducing disparities and improving health of the entire population.

3.2 Background
Stroke and coronary heart disease (CHD), particularly myocardial infarction (MI),
are the leading causes of death and disability among adults in the United States [21].
Despite significant declines in CHD and stroke mortality risks over the past decades,
these conditions continue to be the first and third leading causes of death in the U.S [21]
and Tennessee [465]. Stroke, which is the leading cause of adult disability in the United
States, accounted for approximately 1 out of every 18 deaths (136,000 deaths) in 2007
[21]. Myocardial infarction, also known as heart attack, is responsible for approximately
17 years of life lost in the US and also accounted for about 133,000 deaths in 2007 [21].
Over the past decades, a decline in coronary heart disease and stroke mortality
risks have been observed in the United States [12-15]. For example, from 1997 to 2007,
the annual mortality risk due to CHD declined by 26.3% while that of stroke decreased
by 34.3% [21]. These decreases are attributed to reduction in major population risk
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factors as well as improved medical care [16-19]. Ford et al reported that approximately
47% of the decrease in CHD deaths was attributable to increased use of evidencebased medical therapies and 44% to changes in risk factors in the population due to
lifestyle and environmental changes [19]. However, evidence shows that not all
Americans have benefited from the improved stroke and heart attack outcomes as
some segments of the population have a disproportionate burden of these conditions
[20]. Considerable variability has been observed in the degree to which heart disease
and stroke contribute to the overall burden of death across geographic regions, races,
genders, age groups, and socioeconomic status [14]. For instance, a consistent pattern
of marked geographic variation in stroke mortality within the United States has been
observed, with very high risks reported in the southeast Atlantic coastal plain and very
low risks in the mountain census division [466]. The Southeastern United States, also
known as the “stroke belt” has about 43% greater age-adjusted mortality risk than the
other regions of the United States [467]. Additionally, strong clusters of high CHD
mortality risks especially among women have been observed in Mississippi Delta,
Appalachia, the Ohio River Valley, the Piedmont areas of Georgia, South Carolina, and
North Carolina [183]. Marked race variations in stroke and MI mortality risks have also
been documented in the US with blacks having higher mortality from both diseases
compared with whites [14] and non-Hispanic populations also having relatively high
CHD mortality than whites [183]. Additionally, great disparities in stroke and heart
disease mortality have been observed across socioeconomic status, as measured by
education, income, or occupation with higher risks reported among the poor and undereducated compared to the wealthy and well-educated individuals [183].
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Generally, the underlying causes of disparities in stroke and MI mortality are not
fully understood. However, variation in the prevalence of contributing risk factors has
been implicated as one of the causes for these disparities. It is also known that there is
little data in support of this „risk factor‟ theory [224]. Disparities in awareness as well as
access to information and health services are also responsible for the variations in
stroke and MI mortality risks [20]. Since many risk factors are involved in determining
the observed disparities, it is likely that some risk factors may play more important roles
in disease burdens in some communities than in others. Therefore, investigation of the
geographic patterns in mortality risks, and identification of specific risk factors
responsible for observed patterns would aid in better guiding needs-based health
planning and service provision.
Traditionally, spatial patterns of disease risks have been displayed at larger
geographical units such as state and county levels. However, it has been shown that
analyses performed at large geographic levels may mask the underlying patterns of
disease thus lead to distortion of the underlying spatial patterns [225]. Therefore, use of
finer geographic units such as census tracts may be necessary for more efficient
visualization of the spatial patterns and to better guide disease control efforts and
resource allocation. Thus the objective of this study was to investigate neighborhood
geographic disparities and temporal trends in heart attack and stroke mortality risks in
middle Tennessee and identify determinants/predictors of observed disparities so as to
guide neighborhood health planning programs. Identification of disproportionately
affected neighborhoods will help health planners better target resources and can aid the
development of programs better tailored to specific community needs. This will play a
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key role towards addressing one of the goals of the Healthy People 2020 [438] of
reducing disparities and improving health of the entire population.

3.3 Methods
3.3.1 Study Area
The study was performed in 30 counties of middle Tennessee (Figure 3.1). Most
of these counties lie in the “stroke belt” of Tennessee, a region with high stroke and MI
prevalence. The area consists of 250 census tracts and spans about 12,045 square
miles with a total population of approximately 1.2 million people of which about 88% are
white, about 9% are black and 3% is comprised of other races. Approximately 49% of
the population is male. About 48% of the population is aged between 0 and 34 years.
Sixteen percent, 14%, 9%, and 13% of the population are aged 35-44, 45-54, 55-64,
and ≥65 years, respectively. The region has a mixture of urban and rural areas with
Hamilton being the most urbanized (and most populated) and Pickett least urbanized
(and least populated) counties (Figure 3.1).
3.3.2 Data Sources
3.3.2.1 Mortality and Population Data
Stroke and MI mortality datasets for the period January 1999 through December
2007 were obtained from the Tennessee Department of Health. Deaths from stroke and
MI were defined on the basis of underlying cause of death. The International
Classification of Diseases, Tenth Revision (ICD-10) codes used were I21-I22 for MI and
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Figure 3.1: Map of Middle Tennessee Showing Study Counties and Census Tracts (Neighborhoods)
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I63-I64 for stroke. For each record, we obtained data on address of residence, age,
race, sex, level of education, year of birth, and year of death. These variables were
used for calculation of attribute-specific mortality risks. Cases were geocoded based on
their residential addresses.
The Tennessee 2000 census population, used as the standard population for
direct standardization of the mortality risks, was obtained from the US Census Bureau
[445]. The 2000 US census population estimates were also obtained from the US
Census Bureau and provided denominators used in the computation of the MI and
stroke mortality risks.
3.3.2.2 Cartographic Boundary Files
The cartographic boundary files for counties and census tracts were downloaded
from the US Census Bureau [468] and used for displaying spatial patterns of mortality
risks. Counties are administrative and statistical subdivisions of a state whereas census
tracts are small, county statistical subdivisions that contain between 2,500 and 8,000
people. In this study we use census tracts as proxies for neighborhoods because past
studies have shown that they are good proxies of natural neighborhood boundaries and
are also homogenous with respect to population characteristics [226].
3.3.3 Data Preparation and Statistical Analysis
All the variables in the mortality dataset were assessed for completeness and
accuracy. Impossible entries were identified and corrected, where possible, or otherwise
omitted from further analyses.
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3.3.3.1 Mortality Risk Calculation and Standardization
Attribute-specific mortality risks were computed for the following attributes: sex,
race, education level and age-groups (0-34, 35-44, 45-54, 55-64, 65-74, 75-84, and ≥85
years). Age- and sex-standardized mortality risks were computed by the direct method
using the 2000 Tennessee population as the standard population and expressed as the
number of cases per 100,000 persons. Average annual mortality risks and their 95%
confidence intervals were also computed. All statistical analyses were performed in
Stata version 11.0 (Stata Corp., College Station, TX).
3.3.3.2 Descriptive Statistics
The Shapiro-Wilk test was used to assess the normality of continuous variables.
Since all the continuous variables were not normally distributed, median, minimum and
maximum values were used to summarize the data. Comparisons of the mortality risks
across age groups, sex, race, and education levels were performed using “prtesti”
command in Stata for comparing two proportions. Simes method was used to adjust for
multiple comparisons. Seasonal mortality risks were computed to assess seasonal
differences in MI and stroke mortality risks. Months were aggregated into the traditional
seasons: spring (March, April, and May); summer (June, July, and August); fall
(September, October, and November); and winter (December, January, and February).
3.3.4 Geographic Analysis and Cluster Detection
Spatial empirical Bayesian (SEB) smoothing [225, 469-471], using inverse
distance spatial weights was used to adjust mortality risks for spatial autocorrelation and
variance heterogeneity resulting from inhomogeneous population distribution at the
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census tract and county levels. The spatial empirical Bayesian computed risks enable
better visualization of the spatial patterns compared to the unsmoothed risks when
working with data from small areas [472]. Global Moran‟s I was used to assess for
evidence of significant spatial autocorrelation of the raw (unsmoothed) mortality risks.
Statistical significance of global Moran‟s I was tested using 9,999 permutations using
GeoDa Version 0.9.5i [473].
Spatial clusters of high MI and stroke mortality risks were detected and identified using
Kulldorff‟s spatial scan statistic [474] implemented in SaTScan [475]. Poisson probability
models were used to identify geographical areas (counties and census tracts) with
statistically significant high mortality risks. The maximum spatial cluster size was set at
5% for the total study population. All cartographic displays were done using Arc View
GIS 9.3 [442].
3.3.5 Investigation of Predictors of Spatial Disparities of MI and Stroke Mortality
Predictors of the geographic distribution of MI and stroke mortality risks were
investigated at the census tract spatial scale. Sociodemographic variables considered
for potential association with MI and stroke mortality risks were: sex (proportion of male
and female), race (proportion of white, black, and other), age group (proportion of
individuals in 0-34, 35-44, 45-54, 55-64, ≥65 years categories), marital status
(proportion of single, married, divorced, and widowed), education (proportion of the
population with utmost elementary education, high school, and college education), rural
(proportion of population living in rural areas), poverty (proportion of population living
below poverty level), median household income and median housing value of
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neighborhoods. First, a Poisson model was fit using stepwise backwards elimination
procedure to identify the best main effects model. All possible two-way interaction terms
of variables included in the main effects model were then assessed for significance and
the significant ones were retained in the final model. The final Poisson model was then
assessed for overdispersion using the Pearson and deviance dispersion parameters.
Significant overdispersion for MI (Pearson X2 = 6.25; p <0.0001 and Deviance X2 = 6.29;
p <0.0001) and stroke (Pearson X2 = 2.93; p <0.0001 and Deviance X2 = 2.96; p
<0.0001) models were identified and therefore negative binomial models were fit to the
data using the variables retained in the final Poisson models. Goodness of fit of the
negative binomial models were assessed using Pearson and deviance goodness-of-fit
statistics. Overdispersion of the final negative binomial model was assessed using the
likelihood ratio test (α=0, where α is the dispersion parameter) which compares the
Poisson model to the negative binomial model. Residual diagnostics were performed
using analysis of standardized deviance and Anscombe residuals. All modeling was
done using Stata version 11.0 (Stata Corp., College Station, TX).

3.4 Results
3.4.1 Descriptive Analyses of Cases
3.4.1.1 Age Distribution
A total of 14,741 deaths, 9,822 (66.6%) MI and 4,919 (33.4%) ischemic stroke
were recorded in the study area from January 1999 to December 2007. Myocardial
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infarction mortality cases ranged in age from 8 to 113 years, with 77% of the deaths
occurring in individuals 65 years and older. The median age for women was significantly
(p<0.0001) higher (82 years) than that for men (72 years). Stroke mortality cases
ranged in age from 18 to 107 years with 91% of the deaths occurring in individuals 65
years and older. Similar to MI, the median age of death from stroke for women was
significantly (p<0.0001) higher (84 years) than that for men (79 years).
3.4.1.2 Attribute Specific Mortality Risks
The age-adjusted mortality risk for MI was significantly (p<0.0001) higher in men
(45.6 per 100,000 persons) than women (42.2 per 100,000 persons) (Table 3.1). In
contrast, the age-adjusted mortality risk for stroke was significantly (p<0.0001) higher in
women (28.4 per 100,000 persons) than men (15.5 per 100,000 persons) (Table 3.2).
The highest sex-adjusted age-specific mortality risk for MI (25.9 per 100,000 persons)
was observed in the 75-84 year age group while the lowest (0.4 per 100,000 persons)
was observed in the 0-34 year old age group (Table 3.1). Similar patterns were
observed for stroke with the lowest sex-adjusted age-specific mortality (0.2 per 100,000
persons) being observed in the 0-34 year age group and highest (18.5 per 100,000
persons) among the 85+ year olds (Table 3.2).
Not surprisingly, the age- and sex-adjusted mortality risks for blacks for both MI
(94.7 per 100,000 persons) and stroke (52.5 per 100,000 persons) were significantly
(p<0.0001) higher than those for whites (68.9 per 100,000 persons for MI and 39.6 per
100,000 persons for stroke) (Tables 3.1 and 3.2). The age- and sex-adjusted educationspecific mortality risk for MI was highest among those with utmost elementary school
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Table 3.1: Myocardial Infarction Attribute-specific Mortality Risks for Middle
Tennessee, 1999-2007

Variable

Percentage

Mortality Risk (Per

95% Confidence limits

of Cases

100,000 persons)

of mortality risk

Male

52.7

45.6

44.4 - 46.8

Female

47.3

42.2

40.9 - 43.2

0-34

0.4

0.4

0.3 - 0.5

35-44

2.2

2.0

1.7 - 2.3

45-54

7.0

6.3

5.9 - 6.8

55-64

13.9

12.1

11.5 - 12.7

65-74

19.7

16.9

16.1 - 17.6

75-84

29.3

25.9

25.0 - 26.8

≥85

27.5

23.9

23.1 - 24.8

Black

7.3

94.7

87.9 - 101.5

White

83.7

68.9

67.4 - 70.5

All other races

9.0

648.8

615.2 – 682.4

Utmost Elementary

35.9

182.1

175.0 - 189.2

High school

45.1

115.3

111.9 - 118.6

College and above

15.6

62.5

59.3 - 65.7

Missing

3.4

Sex

Age-group (years)

Race

Education

Season
Winter

27.9

25.4

24.5 - 26.4

Spring

25.1

22.9

21.9 - 23.8

Summer

23.1

21.0

20.2 - 21.9

Fall

23.9

21.8

20.9 - 22.7
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Table 3.2: Stroke Attribute-specific Mortality Risks for Middle Tennessee, 19992007

Variable

Percentage

Mortality Risk (Per

95% Confidence limits

of Cases

100,000 persons)

of mortality risk

Male

36.0

15.5

14.8 - 16.2

Female

64.0

28.4

27.5 - 29.4

0-34

0.4

0.2

0.09 - 0.23

35-44

0.8

0.4

0.3 - 0.5

45-54

1.8

0.8

0.7 - 1.0

55-64

6.1

2.6

2.3 - 2.9

65-74

13.6

5.9

5.4 - 6.3

75-84

34.9

15.6

14.8 - 16.3

≥85

42.4

18.5

17.8 - 19.3

Black

8.2

52.5

47.4 - 57.5

White

82.6

39.6

38.4 - 40.8

All other races

9.2

383.1

356.7 - 409.5

Utmost Elementary

38.0

84.8

80.5 - 89.1

High school

41.5

52.4

50.2 - 54.7

College and above

16.5

37.3

34.7 - 39.8

Missing

4.0

Sex

Age-group (years)

Race

Education

Season
Winter

27.6

12.6

11.9 - 13.3

Spring

25.7

11.7

11.1 - 12.4

Summer

23.0

10.5

9.9 - 11.1

Fall

23.7

10.8

10.2 - 11.4
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education (182.1 per 100,000 persons) and lowest among those with college education
and above (62.5 per 100,000 persons) (Table 3.1). Similar trends were observed for
stroke (Table 3.2).
3.4.2 Temporal Patterns
Generally, there was a gradual decline in the annual mortality risk for MI over the
9 year study period (Figure 3.2). The highest mortality risk was observed in 1999 at
107.5 per 100,000 persons (95% CI: 101.7-113.6) and the lowest was in 2007 at 78.2
per 100,000 persons (95% CI: 73.3-83.4). Although the pattern of change in the stroke
mortality risk over the 9 year period was not very consistent, there was a general
decreasing temporal trend (Figure 3.2). The highest mortality risk being recorded in
2000 at 51.7 per 100,000 persons (95% C1: 47.7-55.9) and the lowest in 2005 at 40.4
per 100,000 persons (95% CI: 36.9-44.2). The highest mortality risk for MI was
observed in winter (25.4 per 100,000 persons) and the lowest in summer (21.0 per
100,000 persons) (Table 3.1). Similarly, the highest mortality risk for stroke was
registered during winter (12.6 per 100,000 persons) and the lowest during summer
(10.5 per 100,000 persons) (Table 3.2). For both conditions, the differences between
winter and summer risks were statistically significant (p<0.05).
3.4.3 Spatial Patterns
Spatial Empirical Bayes smoothed risks for MI ranged from 53.3 to 197.6 per
100,000 persons (for counties) and 10.3 to 300.3 per 100,000 persons (for census
tracts) (Figure 3.3a-b). At the county level, the highest risks of MI were observed in the
northeastern, southwestern and some counties in the central region (Figure 3.3a). In
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Figure 3.2: Annual Mortality Risk for MI and Stroke in Middle Tennessee, 1999-2007
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Figure 3.3: The Spatial Empirical Bayesian Smoothed Mortality Risks of MI at (a)
County and (b) Census Tract/Neighborhood Levels; and of Stroke at (c) County
and (d) Census Tract/Neighborhood Levels in Middle Tennessee, 1999-2007
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addition to the above areas, high mortality risks of MI were also evident in the eastern
part of the study area at the census tract/neighborhood level. Interestingly, high risk
neighborhoods were observed in some seemingly low risk counties. For example,
although Bledsoe, Cumberland, and Rhea counties did not have high MI mortality risks,
they had some neighborhoods with the highest MI mortality risks in the study area
(Figures 3.3a and 3.3b).
For stroke, the SEB smoothed risks ranged from 26.8 to 68.4 (per 100,000
persons) and 10.1 to 152.4 (per 100,000 persons) for counties and neighborhoods,
respectively. Counties with the highest stroke mortality risks were observed mainly in
the south, central and one in the northeast (Figure 3.3c). Similar to MI, seemingly low
risk counties contained some of the very high risk neighborhoods. An example is seen
in Wilson and Cumberland counties (Figure 3.3c and 3.3d).
No evidence of spatial clustering was detected by the global Moran‟s I analysis at
the county level for both MI and stroke. Nevertheless, significant global clustering was
detected at the neighborhood level for both MI (Moran‟s I = 0.181; p = 0.0001) and
stroke (Moran‟s I = 0.090; p = 0.014). However, for both conditions, significant local
clusters (p < 0.05) of high risk were identified at both the county and the neighborhood
levels using Kulldorff‟s spatial scan statistic (Figure 3.4). For MI, a significant (p<0.0001)
high-risk primary cluster comprising of one county (Lincoln) was identified (Figure 3.4a).
This cluster had a relative risk of 1.9, implying that the mortality risk of MI was 1.9 times
higher in this county than other counties in the study area (Table 3.3 and Figure 3.4a).
Six significant (p<0.05) high risk secondary clusters were also identified at the county
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Figure 3.4: Spatial Clustering of Mortality Risks of MI at (a) County and (b) Census
Tract/Neighborhood Levels; and Stroke at (c) County and (d) Census
Tract/Neighborhood Levels in Middle Tennessee, 1999-2007
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Table 3.3: High Risk Clusters of MI Identified at Both the County and Census
Tract (Neighborhood) Levels in Middle Tennessee, 1999-2007

Geographic
Unit

Clusters

Primary Cluster

No. of
locations
in cluster
1

Mortality
Risk

Relative
Risk

p-value

160.3

1.9

<0.0001

Secondary Clusters
County

1

3

126.9

1.5

<0.0001

Level

2

2

121.9

1.4

<0.0001

3

4

120.8

1.4

<0.0001

4

2

105.9

1.2

0.0027

5

1

104.2

1.2

0.010

6

1

106.6

1.2

0.037

13

151.8

1.8

<0.0001

1

6

147.2

1.7

<0.0001

2

4

153.4

1.8

<0.0001

3

1

273.0

3.1

<0.0001

Census tract

4

1

214.4

2.5

<0.0001

Level

5

1

184.1

2.1

<0.0001

6

13

114.1

1.3

<0.0001

7

1

189.4

2.2

<0.0001

8

10

111.6

1.3

0.0001

9

4

118.6

1.4

0.0025

10

1

152.9

1.8

0.0066

11

1

220.2

2.5

0.010

12

1

147.4

1.7

0.012

Primary Cluster
Secondary Clusters
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level (Figure 3.4a, Table 3.3). At the neighborhood level, a significant (p<0.0001) highrisk primary cluster was identified in Giles, Lincoln, and Marshall Counties (Figure 3.4b
and Table 3.3). Several significant (p<0.05) high risk secondary clusters were also
identified at the neighborhood level (Figure 3.4b and Table 3.3). The relative risks for
clusters at the county level ranged from 1.2 to 1.9 while those at the neighborhood level
ranged from 1.3 to 3.1 (Table 3.3).
A significant (p=0.007) high risk primary cluster for stroke was found in White
county (Figure 3.4c and Table 3.4). The risk of stroke mortality in this county was 1.4
times higher than that in other counties in the study area. A high risk secondary cluster
consisting of Cannon and Warren counties was also identified (Figure 3.4c and Table
3.4). Additionally, a significant (p=0.0001) high risk primary cluster located in White,
Warren, Van Buren, and Bledsoe counties was identified at the neighborhood level
(Figure 3.4d, Table 3.4). Five other high risk secondary clusters were also identified
(Figure 3.4d and Table 3.4). It is worth noting that analysis at the neighborhood level
revealed that stroke clusters identified in White, Cannon and Warren counties only
involved one neighborhood in each of the counties and does not involve the whole of
the counties as suggested by the results of the county analysis. Similar situations were
evident for MI clusters at the county and neighborhood levels.
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Table 3.4: High Risk Clusters of Stroke Identified at Both the County and Census
Tract (Neighborhood) Levels in Middle Tennessee, 1999-2007

Geographic
Unit

Clusters

No. of
locations in
cluster
1

Mortality
Risk

Relative
Risk

p-value

58.4

1.4

0.0070

Secondary Cluster

2

52.2

1.2

0.038

Primary Cluster

11

62.9

1.5

<0.0001

1

2

95.2

2.2

<0.0001

2

1

110.2

2.6

<0.0001

3

1

82.1

1.9

0.0075

4

1

83.2

2.0

0.024

5

6

70.0

1.6

0.045

Primary Cluster
County Level

Census tract

Secondary Clusters

Level
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3.4.4 Regression Modeling
The likelihood ratio test of α=0 was significant for both MI (p<0.001) and stroke
(p<0.001) models implying that the negative binomial model seems to fit the data well.
The Pearson and deviance goodness of fit statistics were not significant for both MI
(Pearson p = 0.63 and Deviance p = 0.17) and stroke (Pearson p = 0.48 and Deviance p
= 0.31) models thus confirming that the negative binomial model fits the data well. No
significant outliers and influential observations were observed from residual analyses.
As expected, high MI and stroke mortality risks tended to occur in neighborhoods
with high proportions of the population 65 years and older (Table 3.5). Neighborhoods
with high proportions of individuals with utmost elementary education had higher
mortality risks of MI and stroke (Table 3.5). For MI, neighborhoods that had high
proportions of individuals living in rural areas had high mortality risks while
neighborhoods with high median housing value tended to have lower mortality risks
(Table 3.5). Additionally, neighborhoods in which high proportions of the population
were married tended to have low stroke mortality risks (Table 3.5). More information on
the negative binomial models for MI and stroke can be found in appendix 3 and
appendix 4, respectively.

3.5 Discussion
Results of this study demonstrate spatial disparities of MI and stroke mortality
risks among neighborhoods and population subgroups. For both conditions, women had
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Table 3.5: Negative Binomial Model Results Investigating Predictors of MI and
Stroke Mortality Risks at the Census Tract (Neighborhood) Level in Middle
Tennessee, 1999-2007

Variable
Population Aged
≥65years
Utmost Elementary
MI
Education
Living in Rural
areas
Median housing
value
Population Aged
≥65years
Stroke Utmost Elementary
Education
Population Married

Parameter
Estimate
5.446

Standard
error
0.622

<0.0001

95% Confidence
Interval
4.227 - 6.666

2.605

0.818

0.001

1.003 - 4.207

0.493

0.129

<0.0001

0.239 - 0.746

-0.435

0.119

<0.0001

-0.669 - -0.201

6.512

0.581

<0.0001

5.372 - 7.650

1.495

0.389

<0.0001

0.731 - 2.258

-0.640

0.257

0.013

-1.144 - -0.137
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p-value

a higher median age of death than men because women tend to live longer than men
[392]. Previous studies have shown that over 81% of all CHD [21] and approximately
89% of all stroke [476] deaths occur in individuals that are 65 years and older. Our
study confirms these findings with 77% and 91% of MI and stroke deaths, respectively,
occurring in this age group. Age tends to weaken the heart‟s function as a result of
thickened heart walls as well as thickened and stiffened artery walls. These tend to
increase hypertension which eventually compounds the problem, thus predisposing to
heart attack and stroke [25].
Similar to findings from other reports [12], men had a higher (45.6 per 100,000
persons) age-adjusted mortality risk for MI compared to women (42.2 per 100,000
persons). Evidence shows that men are more likely to suffer a heart attack at a younger
age than women. After 40 years, men have a 49% risk of developing CHD compared to
women (32%) [477]. It is also known that women are protected from heart disease
earlier in life by their sex hormones. However, after menopause the risk of heart disease
in women starts to rise and by 75 years, the risk is equal to or greater than that of men
[25]. In contrast to MI, women had a higher (28.4 per 100,000 persons) age-adjusted
mortality risk of stroke than men (15.5 per 100,000 persons). The differences in stroke
and MI mortality risks for both men and women may reflect differential exposure to
stroke [392] and MI [478] risk factors.
Our results show lowest mortality risk for both stroke and MI in populations that
had college education. This is consistent with other studies that have reported that
indicators of socioeconomic status, such as, level of education are associated with MI
131

[352, 353] and stroke [479, 480] mortality in populations. Kelly and Weitzen found that
people with less than a high school education were more likely to have a myocardial
infarction as compared to college graduates [352]. In the same study, prevalence of MI
was seen to decrease with increase in the life time level of education. Education
influences mortality primarily through factors such as health behavior. The higher an
individual‟s level of education, the more likely that individual is to exercise, drink
moderately, receive preventive medical care, and less likely to smoke [481].
The temporal decreases in MI (27.3%) and stroke (13.4%) mortality risks
between 1999 and 2007 were lower than those recorded nationally (35.3% for MI and
31.5% for stroke) in the same time period [482]. The temporal decrease in the mortality
risk for both MI and stroke may be attributed to improved quality of preventive care and
health services, changes in risk factors and increased awareness of MI symptoms [1618, 483]. Prompt recognition of symptoms and seeking early treatment is essential for
better health outcomes. It is also known that every 30 minutes that elapse before an MI
patient receives treatment increase the mortality risk [21]. Findings of this study are in
agreement with several other studies that have reported high mortality risks from MI
[484-487] and stroke [486, 488-491] during winter and lower mortality risks during
summer. The seasonal variations in mortality have been associated with ambient
temperatures. It is hypothesized that exposure to cold temperatures in winter may
induce physiological stresses such as, sympathetic activation, and hypercoagulability,
which may increase the incidence of MI and stroke [492]. Consistent with findings from
other studies [14, 183, 493], our results show that blacks had a higher mortality risk than
whites for both MI and stroke.
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Significant high-risk clustering was observed at both the county and
neighborhood levels, however, high risk clusters were more refined at the neighborhood
level compared to the county level. For instance, some seemingly low risk counties
contained high risk neighborhoods and within some high risk counties only one or two
neighborhoods had high risks (not the whole county). This implies that assessment of
spatial patterns at larger geographic units tends to mask underlying spatial patterns that
would otherwise be evident at a finer/smaller geographic unit. This result reaffirms that a
smaller geographic unit such as the census tract/neighborhood is better for investigation
of spatial patterns of disease distribution. Moreover, application of these strategies will
enable targeting of limited resources to the highest risk groups thus aid the
development of more needs-based prevention programs. The MI and stroke spatial
patterns observed at the county level are similar to those that have been observed in
other reports [494, 495]. The identified high risk neighborhoods form a baseline for
future interventions and continued surveillance.
The regression modeling results suggest that neighborhoods with higher
proportions of the older population and those with higher proportion of the population
with low education attainment tended to have high MI and stroke mortality risks. The
observed high MI and stroke mortality risks in neighborhoods with high proportions of
individuals aged 65 years and older is not surprising. The association between
education attainment and MI and stroke mortality risk is similar to findings from other
studies [479, 480, 496]. In addition to the above mentioned sociodemographic factors,
marital status was also a predictor of stroke mortality risk. The low risk of stroke
mortality in populations with a high proportion of married individuals could be due to the
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fact that marriage provides social support/security resulting into less distress and
healthier lifestyles [497-499]. It is worthwhile to note that neighborhoods with high
median housing value, another indicator of socioeconomic status, tended to have lower
MI mortality risks compared to those with low median housing value. This reiterates the
importance of socioeconomic status as a risk factor for MI and stroke. As has been
reported by other studies [187], neighborhoods in rural areas were associated with
higher MI mortality risks. Lower socioeconomic status of rural populations and lack of
access to quality care may be responsible for the higher mortality risks in these rural
areas [500]. Lower standards of living and socioeconomic restrictions, in most rural
areas, lead to higher prevalence of CHD risk factors, such as cigarette smoking, poor
dietary habits, sedentary lifestyles, and obesity [501]. Many rural neighborhoods face
barriers such as shortages of health professionals, lack of health insurance,
transportation difficulties, and geographic distance, which impede accessing medical
care, an important determinant of CHD case fatality rates [187] .
Results of this study highlight the need to reduce disparities in stroke and MI
mortality risks among population subgroups and neighborhoods in Middle Tennessee.
Identification and continued monitoring of high risk neighborhoods is an important
component for stroke and MI prevention and treatment efforts. The findings will be
useful for helping public health officials better target resources and control efforts to the
highest risk areas. Health programs targeting high risk neighborhoods should focus on
education on symptom recognition and the importance of seeking treatment promptly for
better health outcomes. Since the treatments for both stroke [429] and MI [424, 425] are
very time sensitive, emergency care treatment guidelines and protocols must also
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ensure that proper diagnosis and evaluation be performed in a timely manner for
patients with stroke and MI symptoms.

3.6 Conclusion
Although the results of this study indicate a decreasing temporal trend in MI and
stroke mortality risks, substantial disparities still exist in some populations and
neighborhoods in the study area. These findings are useful for guiding health planners
in targeting resources and in the development of more needs-based prevention
programs aimed at reducing the burden of MI and stroke in high risk neighborhoods and
improving population health.
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CHAPTER 4
4.0 Summary, Conclusions and Recommendations

This chapter reviews the specific objectives of the study, summarizes the key
findings and provides conclusions and recommendations for future research. The main
goal of the thesis was to investigate neighborhood disparities associated with MI and
stroke in Middle Tennessee. Specific study objectives were to: (i) investigate temporal
changes in geographic disparities of timely access to emergency heart attack and
stroke care in Middle Tennessee, (ii) investigate neighborhood geographic disparities
and temporal trends in heart attack and stroke mortality risks in middle Tennessee and
identify determinants/predictors of observed disparities.
Timely access to MI and stroke care improved over the study period (19992010). There were significant increases in the percentage of the population that had
access to cardiac centers within 30 minutes from 29.4% in 1999 to 62.7% in 2010 while
that for stroke changed from 5.4% in 2004 to 46.1% in 2010. The percentage of the
population that did not have access to cardiac care within 90 minutes decreased from
about 16% in 1999 to zero in 2010 while that for stroke decreased from approximately
52% in 2004 to 5% in 2010. Most (96%) of the population had access to an ED within
30 minutes in 2010. Increase in the number of accredited care centers over the study
period was responsible for the observed increase in access to MI and stroke care.
Whereas most neighborhoods had access to a cardiac center within 90 minutes by
2009, some neighborhoods in Clay, Fentress, Overton, Pickett, Cumberland, Jackson,
Van Buren and White counties did not have access to a stroke center within the same
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travel time in 2010. Most of these neighborhoods were located in the rural areas where
there were fewer care centers. The number of accredited cardiac centers in the study
area increased from 2 in 1999 to 7 in 2010. Notably, there were no accredited stroke
centers in the study area until 2007 and by 2010 there were only 2 stroke centers in the
entire study area. Although the number of cardiac and stroke centers in the study area
increased across the study period, most of the cardiac and stroke centers were located
in the major cities, such as Chattanooga and Murfreesboro.
There was a general decreasing temporal trend of annual mortality risks for both
MI and stroke over the study period. There was approximately a 27% decrease in MI
mortality risk from 107.5 per 100,000 in 1999 to 78.2 in 2007 while that of stroke
decreased by about 9.6% from 47.7 to 43.1 in the same time period. Higher mortality
risks for both MI and stroke were recorded during the winter season. Significant
differences in mortality risks for sex, race, age group and educational level categories
were observed. The MI mortality risk was higher among men than women, whereas
stroke mortality risk was higher among females. For both conditions, individuals ≥65
years, black, and those with utmost elementary education had the highest mortality
risks.
Spatial empirical Bayesian (SEB) risks were computed because they enable
better visualization of spatial patterns compared to unsmoothed (raw) risks as spatial
autocorrelation and variance heterogeneity (resulting from inhomogeneous population
distribution) are adjusted for. The SEB risks for MI ranged from 53.3 to 197.6 per
100,000 persons (for counties) and 10.3 to 300.3 per 100,000 persons (for
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neighborhoods) whereas those for stroke ranged from 26.8 to 68.4 (per 100,000
persons) and 10.1 to 152.4 (per 100,000 persons) for counties and neighborhoods,
respectively. Clusters of high MI and stroke mortality risks were identified at both the
county and neighborhood levels. However, the spatial patterns observed at the
neighborhood level were more refined than those observed at the county level. Some
seemingly low risk counties contained high risk neighborhoods and within some high
risk counties only one or two neighborhoods had high risks. This implies that spatial
patterns observed at lower geographic levels may be more informative for health
planning and resource allocation since they tend to be more refined, thus enable
targeting of limited resources to high risk neighborhoods. Furthermore, high MI and
stroke mortality risks were observed in neighborhoods with high proportions of older
individuals and those with high proportions of individuals with less than high school
education. Additionally, neighborhoods with high proportions of married individuals had
a low mortality risk for stroke. Intervention programs should target these high risk
neighborhoods so as to reduce MI and stroke risk and improve the health of the
population.
Since MI and stroke require time sensitive treatments in order to improve health
outcomes and reduce mortality, identification of neighborhoods without timely access to
care and those with high mortality risks of these conditions is important for needs-based
health planning programs. This will play a major role in achieving one of the goals of the
Healthy people 2020 of reducing health disparities and improving the health of the entire
population. In addition, identification of high risk neighborhoods also ensures continued
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community surveillance of MI and stroke burden trends needed to evaluate the effects
of new health programs and policies.
Currently, most public health intervention programs are based on disease
distribution patterns observed at either the county level or other higher geographic
levels. However, the results of chapter 3 have demonstrated that neighborhoods
provide a more accurate picture of the geographic distribution of mortality risks, thus
reduce the chances of missing disease clusters. To better target high risk populations
and

neighborhoods,

it

would

be

beneficial

for

health

planners

to

use

neighborhood/census tract spatial patterns as the baseline for health programs in order
to better guide resource allocation and disease control efforts.
Disparities

in

geographic

access

to

stroke

care

particularly

in

rural

neighborhoods may be addressed by increased use of telemedicine and air
ambulances. Telemedicine programs for stroke care have been shown to be safe,
feasible, reliable, acceptable, and lead to improved health outcomes [502-504].
Therefore, encouraging increased use of telemedicine can help bridge the gap in
delivery of cardiac and stroke care in geographic settings where timely access to
cardiac and stroke centers is otherwise not possible. Increased use of air ambulances
may be necessary in remote areas or those in which the terrain makes accessibility by
road ambulances challenging. A study carried out in East Tennessee reported that all
neighborhoods had access to MI and stroke care within 30 minutes when air
ambulances were used [22]. Although there may be issues associated with availability
and maintenance of aircrafts, air transport has been reported to be cost effective [131,
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132]. This implies that emergency air ambulances can be used to improve geographic
accessibility to MI and stroke centers in the study area.
Education has been shown to influence MI and stroke mortality risk primarily by
influencing health behaviors such as smoking, high alcohol consumption and inactivity.
Since level of education attained was a significant predictor of both MI and stroke
mortality risks in the neighborhoods, education programs (especially targeting
populations with low education attainment) on symptom recognition as well as the
importance of seeking treatment promptly would be beneficial. As well, health programs
targeting high risk neighborhoods should bolster efforts directed towards education on
benefits of moderate alcohol consumption, physical activity, and smoking cessation.
Further detailed research into the underlying reasons of the observed differences
in MI and stroke mortality between neighborhoods in Middle Tennessee would be
beneficial to further guide health planning and policy. Multilevel analyses combining
individual patient level data with aggregate data is a valuable approach to identify both
individual and area risk factors important in determining most neighborhood variations in
risk. Preventive programs may then focus resources on risk factors with the highest
population attributable fraction so as to reduce disparities and improve health of the
entire population. Thus reduction of MI and stroke burden in Tennessee will be more
efficiently achieved when resources are focused on those risk factors with the highest
attributable risks.
In conclusion, the identified temporal changes in geographic disparities help
highlight progress in access to emergency health services over time as well as identify
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communities that are still underserved. Moreover, the variation in geographical patterns
of MI and stroke mortality risks can help identify and target high risk neighborhoods for
disparity reduction. This is vital for guiding planning and policy decisions aimed at
improving population health.
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Appendix 1: Temporal Changes in the Mortality Risks of Neighborhoods with Access to a Cardiac Center
within Different Travel Time Zones
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Where,
0-30 – Neighborhoods that were within 30 minutes of driving to a cardiac center the
entire study period.
>30-60 – Neighborhoods that were within >30-60 minutes of driving to a cardiac center
the entire study period.
>60-90 – Neighborhoods that were within >60-90 minutes of driving to a cardiac center
the entire study period.
>90 – Neighborhoods that were not within 90 minutes of driving to a cardiac center the
entire study period.
>30-<30 – Neighborhoods that initially were not within 30 minutes of driving to a cardiac
center and at the end had access to a cardiac center within 30 minutes.
>60->3060/>6090 – Neighborhoods that initially were not within 60 minutes of driving to
a cardiac center and at the end had access to a cardiac center within >30-60 and >6090 minutes.
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Appendix 2: Temporal Changes in the Mortality Risks of Neighborhoods with Access to a Stoke Center within
Different Travel Time Zones
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Where,
0-30 – Neighborhoods that were within 30 minutes of driving to a stroke center the
entire study period.
>30-60 – Neighborhoods that were within >30-60 minutes of driving to a stroke center
the entire study period.
>60-90 – Neighborhoods that were within >60-90 minutes of driving to a stroke center
the entire study period.
>90 – Neighborhoods that were not within 90 minutes of driving to a stroke center the
entire study period.
>30-<30 – Neighborhoods that initially were not within 30 minutes of driving to a stroke
center and at the end had access to a stroke center within 30 minutes.
>60->3060 – Neighborhoods that initially were not within 60 minutes of driving to a
stroke center and at the end had access to a stroke center within >30-60 minutes.
>90->6090 – Neighborhoods that initially were not within 90 minutes of driving to a
stroke center and at the end had access to a stroke center within >60-90 minutes.
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Appendix 3: Negative Binomial Model showing the Probability of Death from Heart Attack in the Lowest and
Highest Risk Neighborhoods

Y =-5.557+5.446*AGE65OVER+ 2.605*UTMELEM + 0.493*RURAL – 0.435*MHVALUE – 2.329*RURALUTMELEMT

NEIGHBORHOODS
Lowest risk
1
2
Highest risk
1
2

AGE65
OVER

UTMELEMT

MHVALUE

RURAL

RURAL
UTMELEM

Y

PROBABILITY
OF DEATH

0
0.134

0.533
0.221

1.21400
0.49200

0
1

0
0.221

-4.697
-4.488

0.009
0.011

0.212
0.214

0.230
0.137

0.68400
0.77600

0.302
0.492

0.069
0.068

-4.113
-4.289

0.016
0.014
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Where,
Y – Predicted Mortality risk
AGE65OVER – Proportion of population in the neighborhood above 65 years
UTMELEMT – Proportion of population in the neighborhood with utmost elementary
Education
MHVALUE – Median housing value of neighborhoods
RURAL – Proportion of population in neighborhoods living in rural area

RURALUTMELEM – Interaction between rural and utmost elementary Education

For the 9 year study period, the probability of death from a heart attack in the
neighborhood with the lowest mortality risk was 0.009 whereas that for the
neighborhood with the highest mortality risk was 0.016.
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Appendix 4: Negative Binomial Model showing the Probability of Death from Stroke in the Lowest and Highest
Risk Neighborhoods

Y= -6.169 + 6.512*AGE65OVER + 1.495*UTMELEM – 0.640*MARRIED
NEIGHBORHOODS
Lowest Risk
1
2
Highest Risk
1
2

AGE65OVER

UTMELEMT

MARRIED

Y

PROBABILITY
OF DEATH

0
0.134

0.053
0.221

0.364
0.611

-6.323
-5.357

0.0018
0.0047

0.212
0.208

0.230
0.177

0.524
0.479

-4.779
-4.857

0.0084
0.0078
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Where,
Y – Predicted Mortality risk
AGE65OVER – Proportion of population in the neighborhood 65 years and above
UTMELEMT – Proportion of population in the neighborhood with utmost elementary
Education
MARRIED – Proportion of population in the neighborhood that is married
For the 9 year study period, the probability of death from a stroke in the
neighborhood with the lowest mortality risk was 0.0018 whereas that for the
neighborhood with the highest mortality risk was 0.0084.
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